: The AMEDEO Literature Guide

Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Head and Neck Cancer

Free Subscription

Articles published in BMC Cancer
Retrieve available abstracts of 538 articles:
HTML format

Single Articles

July 2026

LI Y, An H, Yang F, Li H, et al
Neoadjuvant chemoimmunotherapy versus chemotherapy for locally advanced esophageal squamous cell carcinoma: a retrospective cohort study.
BMC Cancer. 2026 Jul 18. doi: 10.1186/s12885-026-16569.
PubMed Abstract available

HUANG Z, Tu X, You Q, Lin D, et al
MR habitat radiomics for differentiating indeterminate (Grade 3) nasopharyngeal lesions: lymphoid hyperplasia versus early-stage nasopharyngeal carcinoma.
BMC Cancer. 2026 Jul 15. doi: 10.1186/s12885-026-16524.
PubMed Abstract available

DING H, Hao S, He G, Zhao K, et al
Development and internal validation of a dynamic Prealbumin-Immune-Inflammation-NLR Prognostic Score (PINPS) for esophageal squamous cell carcinoma treated with immune checkpoint inhibitors: a retrospective cohort study.
BMC Cancer. 2026 Jul 15. doi: 10.1186/s12885-026-16536.
PubMed Abstract available

HUANG D, Han Y, Wu H, Wang Q, et al
Prognostic value of tertiary lymphoid structures in high-risk esophageal squamous cell carcinoma following neoadjuvant chemoimmunotherapy.
BMC Cancer. 2026 Jul 11. doi: 10.1186/s12885-026-16518.
PubMed Abstract available

DONG H, Li Z, Huang H, Liang D, et al
The value of dual-energy computed tomography quantitative parameters in differentiating the sensitivity of small lymph nodes to chemoradiotherapy in nasopharyngeal carcinoma.
BMC Cancer. 2026 Jul 9. doi: 10.1186/s12885-026-16481.
PubMed Abstract available

HSU WC, Yu WP, Han HM, Kao HK, et al
Psychometric and structural properties of Traditional Chinese version of postoperative oral dysfunction-10 in patients with oral cancer undergoing facial free flap reconstruction surgery.
BMC Cancer. 2026 Jul 6. doi: 10.1186/s12885-026-16470.
PubMed Abstract available

LIAO ZW, Xu Q, Sun XS, Lin C, et al
Intensity-modulated radiotherapy alone versus concurrent chemoradiotherapy +/- induction chemotherapy in older patients with low-risk stage II or T3N0M0 nasopharyngeal carcinoma.
BMC Cancer. 2026 Jul 4. doi: 10.1186/s12885-026-16457.
PubMed Abstract available

ABU HEJLEH A, Lemties J, Kreutzer I, Wirsik NM, et al
Complications and survival after Ivor Lewis esophagectomy.
BMC Cancer. 2026;26:802.
PubMed Abstract available

HE L, Zeng Y, Gao Y, Xie X, et al
Network-based integrative transcriptomic analysis reveals immune-regulatory and oncogenic signatures of EOMES and SPRYD3 in head and neck squamous cell carcinoma.
BMC Cancer. 2026 Jul 1. doi: 10.1186/s12885-026-16379.
PubMed Abstract available

June 2026

HEFZI D, Koopaie M, Hakimiha N, Younespour S, et al
Nano-silymarin combined with methylene blue photodynamic therapy versus monotherapies of head and neck squamous cell carcinoma: in-vitro study.
BMC Cancer. 2026 Jun 29. doi: 10.1186/s12885-026-16422.
PubMed Abstract available

LIN Z, Song W, Liang W, Liu J, et al
Potential evaluation of SULT1A3 as an early diagnostic marker for nasopharyngeal carcinoma: a study based on serum proteomics screening and ELISA validation.
BMC Cancer. 2026 Jun 27. doi: 10.1186/s12885-026-16428.
PubMed Abstract available

KAPOOR A, Gupta A, Sansar B, Mishra BK, et al
Immuno-oncology in the perioperative setting: the next frontier in resectable head and neck cancers - a systematic review.
BMC Cancer. 2026 Jun 26. doi: 10.1186/s12885-026-16304.
PubMed Abstract available

CAI Y, Wei N, Zhang J, Lin R, et al
Prognostic significance of pretreatment pan-immune inflammation value in esophageal squamous cell carcinoma patients undergoing definitive chemoradiotherapy.
BMC Cancer. 2026 Jun 26. doi: 10.1186/s12885-026-16369.
PubMed Abstract available

YOU T, Huan F, Luo Z, Ma Y, et al
Machine learning-powered audio-omics processing method as an auxiliary diagnostic approach for advanced nasopharyngeal carcinoma.
BMC Cancer. 2026 Jun 24. doi: 10.1186/s12885-026-16374.
PubMed Abstract available

LUO M, Zhu D, Yin X
Sanguinarine as a multi-target therapeutic candidate for laryngeal cancer: insights from network pharmacology, molecular dynamics and in vitro validation.
BMC Cancer. 2026 Jun 20. doi: 10.1186/s12885-026-16377.
PubMed Abstract available

YE Y, Song R, Zhao F, Chen L, et al
Self-perceived burden and quality of life in patients with radiation-induced brain injury after radiotherapy for nasopharyngeal carcinoma: a cross-sectional study on the mediating role of stigma and the moderating role of sleep quality.
BMC Cancer. 2026 Jun 17. doi: 10.1186/s12885-026-16375.
PubMed Abstract available

GREIER MDC, Dudas J, Federspiel J, Ferro F, et al
Granzyme B, HIF-1alpha, VEGFA and SerpinB9 in the local tumour immune system of immune-stimulated slice cultures of head and neck cancer.
BMC Cancer. 2026 Jun 11. doi: 10.1186/s12885-026-16282.
PubMed Abstract available

ZHANG B, Zhang H, Zheng H, Xie X, et al
Prognostic significance and optimal staging of supraclavicular lymph node metastasis in upper esophageal squamous cell carcinoma undergoing chemoradiotherapy.
BMC Cancer. 2026 Jun 8. doi: 10.1186/s12885-026-16306.
PubMed Abstract available

HUANG TC, Liang CW, Li YI, Guo JC, et al
Tertiary lymphoid structures predict outcomes of neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma.
BMC Cancer. 2026 Jun 1. doi: 10.1186/s12885-026-16163.
PubMed Abstract available

May 2026

YANG Y, Luo Y, Wu T, Huang G, et al
Effect of body mass index and age on the prognosis of non-metastatic nasopharyngeal carcinoma.
BMC Cancer. 2026 May 29. doi: 10.1186/s12885-026-16276.
PubMed Abstract available

MEHTA V, Fraile JF, Mathur A, Bhadania M, et al
Effects of metformin on head and neck cancer: an umbrella review.
BMC Cancer. 2026 May 29. doi: 10.1186/s12885-026-16057.
PubMed Abstract available

PAN D, Xu Y, Tao Y, Huang F, et al
A pilot study assessing the feasibility of contrast-enhanced ultrasound for triaging fine-needle aspiration in lateral cervical lymph nodes of papillary thyroid carcinoma.
BMC Cancer. 2026 May 28. doi: 10.1186/s12885-026-16243.
PubMed Abstract available

DUAN C, Yu P, Wei X, Zhong J, et al
The role of age and antibodies in central regional lymph node metastases of papillary thyroid carcinoma combined with hashimoto's thyroiditis.
BMC Cancer. 2026 May 27. doi: 10.1186/s12885-026-16229.
PubMed Abstract available

SUN Z, Lin D, Liu Y, Li S, et al
Serum amyloid A kinetics predicts outcomes to PD-1 inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma.
BMC Cancer. 2026 May 26. doi: 10.1186/s12885-026-16220.
PubMed Abstract available

UHL B, Eggert D, Smiljanov B, von Thun Und Hohenstein K, et al
Targeting EpCAM expression via near-infrared fluorescent antibodies enables microscopic delineation of primary and recurrent HNSCC.
BMC Cancer. 2026;26:671.
PubMed Abstract available

KOROGLU EY, Evranos Ogmen B, Deniz MS, Saylam B, et al
Surgical extent, tumor size, and calcitonin levels in medullary thyroid carcinoma: impact on oncologic outcomes in a retrospective cohort study.
BMC Cancer. 2026 May 25. doi: 10.1186/s12885-026-16218.
PubMed Abstract available

SOLEIMANI SARDOU S, Rezvaninejad R, Rezvaninejad FS, Nekouei AH, et al
Artificial intelligence for oral cancer diagnosis: a systematic review and meta-analysis of image-based and non-imaging models.
BMC Cancer. 2026 May 25. doi: 10.1186/s12885-026-16154.
PubMed Abstract available

BAI Y, Dong X, Qian Y, Chen L, et al
Spatial nodal pattern refines disease-free survival stratification beyond pathological N stage in resected esophageal squamous cell carcinoma.
BMC Cancer. 2026 May 20. doi: 10.1186/s12885-026-16197.
PubMed Abstract available

SAHIN CELIK B, Agdas G, Genc V
Comparison of perioperative chemotherapy and neoadjuvant chemoradiotherapy (CRT) in locally advanced resectable distal esophageal/esophagogastric junction (EGJ) adenocarcinomas.
BMC Cancer. 2026;26:758.
PubMed Abstract available

LIU D, Zhang X, Zhang J, Zhao K, et al
Extensive-stage small cell esophageal carcinoma: a retrospective analysis of treatment modalities.
BMC Cancer. 2026;26:853.
PubMed Abstract available

LIU M, Tian H, Wang M, Guo C, et al
Lipid-dominated metabolites mediate the association between low body mass index and esophageal malignancy: a population-based nested case-control study.
BMC Cancer. 2026;26:819.
PubMed Abstract available

KHAN R, Kainat N, Riaz A, Shamas S, et al
Expressional deregulations of RET/PTC genes and different nutritional factors playing crucial role in the development of thyroid cancer in Pakistani female subjects.
BMC Cancer. 2026 May 12. doi: 10.1186/s12885-026-16144.
PubMed Abstract available

YOUNG S, Moon DH, Wang J, Chen L, et al
Involved nodal versus elective neck radiotherapy (INVERT) for head and neck squamous cell carcinoma: a prospective phase II randomized controlled trial protocol.
BMC Cancer. 2026 May 11. doi: 10.1186/s12885-026-15904.
PubMed Abstract available

LI R, Huang HQ, Yang LH, Zhou ZY, et al
Efficacy and safety of concurrent chemoradiotherapy combined with immunotherapy for locally advanced esophageal squamous cell carcinoma: a retrospective cohort study.
BMC Cancer. 2026 May 11. doi: 10.1186/s12885-026-16162.
PubMed Abstract available

YI W, Muhetaer K, Chen L, Ma X, et al
Immunotherapy combined with chemotherapy as first-line treatment for HER2-negative advanced gastric or gastroesophageal junction cancer: systematic review and Bayesian network meta-analysis based on specific PD-L1 expression levels.
BMC Cancer. 2026;26:780.
PubMed Abstract available

LI H, Chen Y, Guo G, Luo Q, et al
PPP4C: a potential molecular marker and therapeutic target in thyroid cancer and triple-negative breast cancer.
BMC Cancer. 2026 May 4. doi: 10.1186/s12885-026-16083.
PubMed Abstract available

April 2026

SUN J, He W, Sun S, Ma D, et al
Downregulation of SPINK5 promotes laryngeal cancer cell malignancy through activation of KLK6-dependent glycolysis.
BMC Cancer. 2026 Apr 30. doi: 10.1186/s12885-026-15958.
PubMed Abstract available

LINGE A, Lohaus F, Appold S, Troost EGC, et al
De-escalation of adjuvant radio(chemo)therapy for patients with HPV-positive head and neck squamous cell carcinoma: study protocol for a phase I trial to reduce late toxicity (DELPHI).
BMC Cancer. 2026;26:542.
PubMed Abstract available

LUO T, Xiong J, Yang H, Xiang J, et al
The prognostic value of neutrophil-to-albumin ratio for dual outcomes in locally advanced esophageal cancer: an integrated analysis based on propensity score matching and Lasso-Cox regression.
BMC Cancer. 2026 Apr 29. doi: 10.1186/s12885-026-16094.
PubMed

DONG H, Wang Y, Gao P, Yao L, et al
Association of stromal tumor infiltrating lymphocytes and body mass index with prognosis in esophageal squamous cell carcinoma patients.
BMC Cancer. 2026 Apr 28. doi: 10.1186/s12885-026-16045.
PubMed

QIU X, Cheng L, Jin Y, Fu H, et al
Disease status stratification individualizes radioiodine therapy for differentiated thyroid cancer: a prospective, multicenter, real-world study.
BMC Cancer. 2026 Apr 24. doi: 10.1186/s12885-026-16030.
PubMed

EMMA R, Carota G, Partsinevelos K, Rust S, et al
Effect of electronic cigarette aerosols on cisplatin resistance in head and neck cancer cells: a collaborative replication study.
BMC Cancer. 2026 Apr 22. doi: 10.1186/s12885-026-16029.
PubMed

LIN X, Mo F, Zhang B, Pan Y, et al
SARS-CoV-2 infection and its effects on toxicity and survival in non-metastatic nasopharyngeal carcinoma: a matched cohort study.
BMC Cancer. 2026 Apr 22. doi: 10.1186/s12885-026-16038.
PubMed

HUANG G, Zhang L, Zhu J, He B, et al
The impact of low skeletal muscle index and low muscle radiodensity on the prognosis of esophageal squamous cell carcinoma: a multi-center retrospective study in China (TIMES Study).
BMC Cancer. 2026 Apr 21. doi: 10.1186/s12885-026-16048.
PubMed

ZHANG W, Zhu J, Zhang Y, Zhang X, et al
Development of a clinically applicable prediction tool for lymph node metastasis in papillary thyroid carcinoma using lasso-logistic regression.
BMC Cancer. 2026 Apr 17. doi: 10.1186/s12885-026-16047.
PubMed

COOK F, Saeed A, Govender R, Vindrola-Padros C, et al
Postoperative feeding practices and nutritional intake in patients with head and neck cancer undergoing surgery with flap tissue transfer reconstruction: a scoping review.
BMC Cancer. 2026 Apr 16. doi: 10.1186/s12885-026-15973.
PubMed

DOUYAT LM, Spencer A
The effectiveness of gender-neutral HPV vaccination programmes in preventing HPV-associated oral cancers: a systematic review.
BMC Cancer. 2026 Apr 16. doi: 10.1186/s12885-026-15979.
PubMed

ABDULLAHI IM, Yasin NA, Adani AA, Ali IM, et al
Correlation between fine needle aspiration cytology with histopathology of non-thyroidal head and neck lesions: first report from Somalia.
BMC Cancer. 2026 Apr 16. doi: 10.1186/s12885-026-16018.
PubMed

ZHOU P, Liu X, Huang S, Luo Y, et al
Efficacy of PD-1 inhibitor plus induction chemotherapy for nasopharyngeal carcinoma with high-grade extranodal extension: a multicenter retrospective analysis.
BMC Cancer. 2026 Apr 15. doi: 10.1186/s12885-026-15995.
PubMed

CHEN R, Ding Y, Zhao L, Yu Z, et al
Development and validation of a metabolic-inflammatory-nutritional prognostic model for esophageal squamous carcinoma.
BMC Cancer. 2026 Apr 15. doi: 10.1186/s12885-026-16007.
PubMed

XUE W, Valderrama A, Ramakrishnan K, Zhou J, et al
Event-free survival as a surrogate for overall survival in locally advanced esophageal cancer: a correlation analysis of trials assessing definitive chemoradiation therapies.
BMC Cancer. 2026 Apr 10. doi: 10.1186/s12885-026-15914.
PubMed

LIN B, Yu X, Li M, Mao W, et al
Transcriptome and experimental validation identify prognostic genes associated with lipotoxicity in thyroid carcinoma.
BMC Cancer. 2026 Apr 9. doi: 10.1186/s12885-026-15975.
PubMed

ARENDS CR, van der Molen L, van den Brekel MWM, Stuiver MM, et al
Lived experience of having lymphedema after treatment of head and neck cancer: a qualitative study.
BMC Cancer. 2026 Apr 6. doi: 10.1186/s12885-026-15933.
PubMed

March 2026

MIAO J, Cheng W, Ding L, Fu H, et al
Comparative outcomes of retreatment vs follow-up in DTC patients with intermediate response following initial radioactive iodine therapy: a retrospective cohort study.
BMC Cancer. 2026;26:594.
PubMed Abstract available

TAWAKOLI MF, Salihee H, Rahmati A, Hatami MN, et al
Hospital-based patterns of esophageal and gastric cancer cases at a major tertiary referral center in Kabul, Afghanistan: a retrospective case series.
BMC Cancer. 2026 Mar 29. doi: 10.1186/s12885-026-15945.
PubMed

ZHU L, Zeng F, Chen K, Li L, et al
Impact of concurrent chemotherapy dose on long-term survival in locally advanced nasopharyngeal carcinoma: a 10-year single-center study.
BMC Cancer. 2026 Mar 28. doi: 10.1186/s12885-026-15873.
PubMed

KHALID Z, Khan K, Nazir F, Yao C, et al
Identification and validation of hub genes involved in papillary thyroid carcinoma progression.
BMC Cancer. 2026 Mar 19. doi: 10.1186/s12885-026-15841.
PubMed

SENEVIRATHNA K, Francis AH, Pirzada M, Mahakapuge TAN, et al
An exploratory ATR-FTIR spectroscopic study of serum protein structural alterations in oral squamous cell carcinoma and oral potentially malignant disorders.
BMC Cancer. 2026;26:539.
PubMed Abstract available

HAN Y, Wang Q, Chen Y, Wu H, et al
Platinum-free triplet therapy with nab-paclitaxel, S-1, and tislelizumab as first-line treatment for advanced gastric/gastroesophageal junction adenocarcinoma: a phase ii single-arm trial.
BMC Cancer. 2026;26:546.
PubMed Abstract available

TANG P, Gao L, Zuo S, Zhang K, et al
Adebrelimab plus chemotherapy as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESCC): a single-center, phase II, single-arm, open-label clinical trial (ADENEO) protocol.
BMC Cancer. 2026 Mar 13. doi: 10.1186/s12885-026-15850.
PubMed

YUAN CH, Ke HL, Jhan JH, Chu TH, et al
High VRK2 expression level predicts unfavorable survival outcomes in nasopharyngeal carcinoma.
BMC Cancer. 2026 Mar 13. doi: 10.1186/s12885-026-15804.
PubMed

ZHANG G, Xu X, Hong R, Han X, et al
An explainable radiomics model based on multiparametric magnetic resonance for differentiating benign and malignant orbital tumors.
BMC Cancer. 2026 Mar 13. doi: 10.1186/s12885-026-15853.
PubMed Abstract available

INCHANALKAR M, Chavda R, Gawde J, Patil A, et al
Upregulation of Derlin 3 (DERL3) protein expression is associated with Oral Cancer progression and is independent of promoter hypermethylation.
BMC Cancer. 2026 Mar 13. doi: 10.1186/s12885-026-15856.
PubMed

WANG L, Mao W, Deng H, Zhou WP, et al
Diagnostic accuracy in BRAF V600E-negative papillary thyroid cancer via 5-gene expression profiling of residual nucleic acids from mutation testing: a retrospective study.
BMC Cancer. 2026 Mar 10. doi: 10.1186/s12885-026-15818.
PubMed

SMITH G, Boey TY, Chu SY, Chan CMH, et al
Experiences of swallowing and communication after nasopharyngeal cancer in Malaysian men: a qualitative study.
BMC Cancer. 2026;26:490.
PubMed Abstract available

AGATE S, Patil S, Sarade M, Lokhande D, et al
Overall survival of oral cancer from the population-based cancer registries of the Konkan area, Maharashtra, India.
BMC Cancer. 2026 Mar 9. doi: 10.1186/s12885-026-15689.
PubMed

ZHOU G, Sijtsema NM, Li Y, Zhai T, et al
Prediction of treatment outcome in nasopharyngeal carcinoma patients.
BMC Cancer. 2026 Mar 9. doi: 10.1186/s12885-026-15570.
PubMed

LIN W, Xiao L, Chen J, Lin X, et al
Comparison of six-degree-of-freedom registration errors across different anatomical registration regions in head and neck radiotherapy under identical CBCT conditions.
BMC Cancer. 2026;26:477.
PubMed Abstract available

WU H, Yuejiao D, Hong L, Qin J, et al
IL-23 as a potential mediator of immune evasion and therapeutic target in laryngeal squamous cell carcinoma.
BMC Cancer. 2026;26:464.
PubMed Abstract available

February 2026

SI L, Zhao C, Chard Dunmall LS, Wang P, et al
Oncolytic adenovirus type 11-induced ferroptosis of esophageal squamous cell carcinoma cells involves in mitochondrial impairment and the mTOR pathway.
BMC Cancer. 2026 Feb 24. doi: 10.1186/s12885-026-15735.
PubMed

SHI J, Liu J, Xu Z, Chen M, et al
Association of sarcopenia with pathologic complete response in esophageal squamous cell carcinoma patients undergoing neoadjuvant immunochemotherapy.
BMC Cancer. 2026 Feb 23. doi: 10.1186/s12885-026-15782.
PubMed

HU S, Wang Q, Wei H, Sun H, et al
Long non-coding RNA HOXC-AS3 promotes proliferation and metastasis of esophageal squamous carcinoma by targeting WNT3A through binding to YBX1.
BMC Cancer. 2026;26:381.
PubMed Abstract available

HAO MY, Li FY, Zhang SM, Yang YX, et al
Malnutrition-related symptom clusters and quality of life in nasopharyngeal carcinoma patients during radiotherapy: a network analysis.
BMC Cancer. 2026 Feb 13. doi: 10.1186/s12885-026-15694.
PubMed Abstract available

OWIBINGIRE SS, Minja IK, Simon EN, Costea DE, et al
Assessing the covariates of delay in seeking health care among patients with oral and oropharyngeal squamous cell carcinoma in Tanzania.
BMC Cancer. 2026;26:392.
PubMed Abstract available

ADEM JB, Adilo AM, Deybasso HA, Kabeto M, et al
Lived experience and attitudes of esophageal cancer patients toward stenting-based care at Asella referral hospital: a qualitative exploration from a resource-limited setting in South-Eastern Ethiopia.
BMC Cancer. 2026 Feb 7. doi: 10.1186/s12885-026-15707.
PubMed

LI H, Lou P, Huang Y, Ma J, et al
Nomogram for predicting papillary thyroid carcinoma risk combined with clinical, biochemical and ultrasonographic indicators.
BMC Cancer. 2026 Feb 5. doi: 10.1186/s12885-026-15686.
PubMed

LAMY C, Laurent L, Choussy O, Pouget N, et al
SCANDARE: an institutional dynamic prospective interventional biobanking study.
BMC Cancer. 2026;26:330.
PubMed Abstract available

January 2026

ANBARI F, Heydari SM, Bakhtiari S, Younesi Pour Masouleh S, et al
Effect of alpha-lipoic acid on salivary secretion in patients undergoing head and neck radiotherapy: a randomized clinical trial.
BMC Cancer. 2026;26:318.
PubMed Abstract available

SATHASIVAM HP, Japar R, Alias Z, Zakaria Z, et al
Human papillomavirus (HPV) - driven head and neck squamous cell carcinoma (HNSCC) in a multi-ethnic developing country.
BMC Cancer. 2026 Jan 30. doi: 10.1186/s12885-026-15550.
PubMed Abstract available

HUANG D, Guo Y, Chen M, Chen G, et al
Multi-omics characterization of C4orf19 in HNSCC: constructing prognostic signatures for immunotherapy and chemotherapy response prediction.
BMC Cancer. 2026;26:309.
PubMed Abstract available

SAKAI H, Shibata A, Miyamoto K, Matsuzawa K, et al
Practice and impact of selection and centralization for oral cancer services: a scenario analysis.
BMC Cancer. 2026 Jan 28. doi: 10.1186/s12885-026-15617.
PubMed

WANG L, Li Y, Qiu T, Liu J, et al
Improving prediction accuracy of radiation-induced temporal lobe injury in nasopharyngeal carcinoma using ADC-based deep learning and dosiomics.
BMC Cancer. 2026 Jan 28. doi: 10.1186/s12885-026-15599.
PubMed Abstract available

LIU L, Zhang X, Zeng C, Hu Y, et al
Younger women with esophageal carcinoma exhibit improved prognosis after esophagectomy: a single-center, high-volume cohort study.
BMC Cancer. 2026;26:303.
PubMed Abstract available

ZHANG Y, Zhu H, Yang F, Yang L, et al
Construction and validation of a prediction model for postoperative complications of elderly patients with locally advanced esophageal squamous cell carcinoma based on POSSUM system and inflammatory factors.
BMC Cancer. 2026 Jan 27. doi: 10.1186/s12885-026-15559.
PubMed

ZHU PF, Zhang XF, Mao YX, Zhou P, et al
Predicting central lymph node metastasis in papillary thyroid carcinoma using a fusion model of vision transformer and traditional radiomics based on dynamic dual-modality ultrasound.
BMC Cancer. 2026 Jan 26. doi: 10.1186/s12885-025-15153.
PubMed Abstract available

SCHOFFER O, Kemper M, Gerken M, Bierbaum V, et al
The effects of certification of head and neck cancer centers on the survival of patients with a head and neck cancer.
BMC Cancer. 2026;26:132.
PubMed Abstract available

LUO C, Li J, Mu W, Yuan M, et al
The value of 3D contrast-enhanced CT radiomics in predicting response to neoadjuvant chemotherapy for adenocarcinoma of the esophagogastric junction: a two-center study.
BMC Cancer. 2026;26:259.
PubMed Abstract available

ZHANG Y, Xu S, Hu Y
Integrated primary tumor and all metastatic lymph nodes radiomics from 18 F-FDG PET/CT for precise M1 subclassification in nasopharyngeal carcinoma.
BMC Cancer. 2026 Jan 21. doi: 10.1186/s12885-026-15589.
PubMed

LIMA EDNS, Ferreira IB, de Paiva Maia YC, Pena GDG, et al
Associations of nutritional risk, pre-treatment malnutrition, and cachexia with mortality, local recurrence, and metastasis in head and neck cancer: a five-year prospective cohort study.
BMC Cancer. 2026 Jan 17. doi: 10.1186/s12885-025-15373.
PubMed Abstract available

BUKURU J, Sibomana O
Comparative analysis of prevalences of sensorineural hearing loss from chemoradiotherapy versus radiotherapy in head and neck cancer patients: a systematic review and meta-analysis.
BMC Cancer. 2026 Jan 14. doi: 10.1186/s12885-026-15551.
PubMed Abstract available

ZHANG H, Yang Y, Li R, Bai X, et al
A prognostic nomogram for elderly patients with inoperable esophageal cancer undergoing intensity-modulated radiotherapy.
BMC Cancer. 2026 Jan 13. doi: 10.1186/s12885-026-15565.
PubMed Abstract available

LI X, Sun X, Gu Q, Long Z, et al
IGF2BP3/m6A-mediated intron retention isoform of DUSP6 promotes cisplatin resistance in nasopharyngeal carcinoma by inhibiting pyroptosis.
BMC Cancer. 2026 Jan 12. doi: 10.1186/s12885-025-15337.
PubMed

YE G, Pan G, Lin S, Jiang J, et al
Tumor volume change rate based on three-dimensional reconstruction as a predictor of pathological response and survival prognosis in esophageal squamous cell carcinoma with neoadjuvant immunochemotherapy.
BMC Cancer. 2026 Jan 10. doi: 10.1186/s12885-025-15497.
PubMed

ZHU Y, Chen T, Chen S, Bai G, et al
A radiomics and machine learning-based method for dynamic assessment of tumor burden after neoadjuvant therapy in esophageal cancer.
BMC Cancer. 2026 Jan 5. doi: 10.1186/s12885-025-15520.
PubMed

LIU PT, Chiang CJ, Yang YW, Lee WC, et al
Prognostic heterogeneity of HPV-associated oropharyngeal cancer in a Taiwanese population.
BMC Cancer. 2026 Jan 5. doi: 10.1186/s12885-025-15528.
PubMed Abstract available

December 2025

UDEABOR SE, Ishfaq M, Shah SJ, Khalid I, et al
Discovery of novel FGFR1 inhibitors for oral squamous cell carcinoma using a multi-class QSAR model, virtual screening, and molecular dynamics simulations.
BMC Cancer. 2025;26:146.
PubMed Abstract available

BAKHSHANDEH M, Mohammadi P, Parvaz N, Lotfi M, et al
Study of FOXO1/pFOXO1, lncRNA ADAMTS9-AS2, and miR-96-5p in laryngeal squamous cell carcinoma.
BMC Cancer. 2025;25:1882.
PubMed Abstract available

BABA AM, Shyanti RK, Hajam MA, Nissa N, et al
Role of histone acetylation in the regulation of CD36 and ANGPTL1 in esophageal squamous cell carcinoma.
BMC Cancer. 2025 Dec 23. doi: 10.1186/s12885-025-15350.
PubMed

MA S, Wang Y
LINC-PINT expression and rs1059698 polymorphism associate with chemoradiotherapy efficacy in Chinese nasopharyngeal carcinoma patients.
BMC Cancer. 2025 Dec 18. doi: 10.1186/s12885-025-15415.
PubMed Abstract available

OBAYASHI F, Koizumi K, Ito N, Higaki M, et al
Preliminary study for the development of enhanced recovery after surgery program for free flap reconstruction in older population with advanced oral cancer: a single-center retrospective study.
BMC Cancer. 2025;25:1872.
PubMed Abstract available

ZEYNELGIL E, Kavak EE, Dilli I, Isak OA, et al
BMI and PNI as predictors of treatment completion and survival in locally advanced HNSCC receiving sequential chemoradiotherapy.
BMC Cancer. 2025;25:1869.
PubMed Abstract available

ZHANG C, Li L, Liu Y, Yu B, et al
Engineered hUCMSC-derived extracellular vesicles deliver circ-0000258 to restore p53-mediated tumor suppression in papillary thyroid carcinoma.
BMC Cancer. 2025;25:1868.
PubMed Abstract available

SOLEIMANI SARDOU S, Ghaemi MM, Rezvaninejad FS, Seyrfar A, et al
"Enhancing early detection of oral cancer: a comparative study of artificial intelligence models and clinical specialist in lesion classification".
BMC Cancer. 2025 Dec 15. doi: 10.1186/s12885-025-15334.
PubMed Abstract available

ZENG H, Wu YL, Wang X, Bai H, et al
Efficacy and safety of radiotherapy in first-line treatment for de novo advanced esophageal cancer in the era of immunochemotherapy: a systematic review and meta-analysis.
BMC Cancer. 2025 Dec 15. doi: 10.1186/s12885-025-15420.
PubMed Abstract available

BAO R, Liao J
Mechanistic study of HIF-1alpha-mediated regulation of the Notch1 pathway in promoting radioresistance in head and neck squamous cell carcinoma: a comprehensive analysis based on bioinformatics and functional experiments.
BMC Cancer. 2025 Dec 12. doi: 10.1186/s12885-025-15428.
PubMed Abstract available

RAN X, Zhang C, Zheng L, Luo T, et al
Peripheral blood cells predict the efficacy and prognosis of neoadjuvant immunotherapy combined with chemotherapy for esophageal squamous cell carcinoma.
BMC Cancer. 2025;25:1865.
PubMed Abstract available

LIN D, Jia Q, Zhang X, Shan C, et al
SHMT1, an amino acid metabolism-related gene, is an independent prognostic biomarker in laryngeal squamous cell carcinoma.
BMC Cancer. 2025;25:1859.
PubMed Abstract available

SU Z, Tang J, Yin C, He Y, et al
Prognostic value of thrombocytosis in nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.
BMC Cancer. 2025 Dec 8. doi: 10.1186/s12885-025-15400.
PubMed Abstract available

QUAN J, Zhou A, Guo Z, Chen Y, et al
The nasopharyngeal carcinoma in Xiamen China from 2011 to 2020: a population-based linkage study.
BMC Cancer. 2025 Dec 8. doi: 10.1186/s12885-025-15394.
PubMed Abstract available

MOTTAGHI M, Jafari F, Nejati M, Farshad F, et al
Mitochondrial DNA mutations in head and neck squamous cell carcinoma: a systematic review and meta-analysis.
BMC Cancer. 2025 Dec 6. doi: 10.1186/s12885-025-15386.
PubMed Abstract available

LIU Y, Sun R, Liu J, Li Q, et al
Identification and validation of key biomarkers for chemoresistance in oral squamous cell carcinoma.
BMC Cancer. 2025;26:67.
PubMed Abstract available

PARK S, Lee JS, Jeong HJ, Yun HJ, et al
Methionyl-tRNA synthetase 1 expression, the possibility as a diagnostic and prognostic factor in papillary thyroid cancer.
BMC Cancer. 2025;25:1850.
PubMed Abstract available

SAKANAKA K, Sasaki K, Tsushima T, Machida R, et al
Study protocol of a randomized controlled phase II trial comparing nivolumab, ipilimumab plus radiotherapy versus nivolumab plus ipilimumab for advanced or recurrent esophageal cancer: Japan Clinical Oncology Group study JCOG2311 (ART NOUVEAU).
BMC Cancer. 2025 Dec 3. doi: 10.1186/s12885-025-15403.
PubMed Abstract available

HE SQ, Lv SH, Wen SQ, Wang L, et al
Efficacy of metastasis-directed therapy in de novo metastatic nasopharyngeal carcinoma patients receiving chemo-immunotherapy and local regional radiotherapy: a multicenter retrospective study.
BMC Cancer. 2025;25:1847.
PubMed Abstract available

YANG S, Jiang H, Zhong L, Makelike K, et al
Albumin-bound paclitaxel and cisplatin with radiotherapy in locally advanced oesophageal squamous cell carcinoma: a single-arm, phase II trial.
BMC Cancer. 2025;25:1840.
PubMed Abstract available

November 2025

BAYRAK AF, Arayici ME, Savas O, Ozgur E, et al
Prognostic impact of Fusobacterium nucleatum in head and neck cancers: a meta-analysis of critical oncological outcomes.
BMC Cancer. 2025 Nov 29. doi: 10.1186/s12885-025-15404.
PubMed Abstract available

HE Y, Shuai R, Wu J, Zhou L, et al
Unveiling the ITGbeta1-CLIC1 axis: a new frontier in oral squamous cell carcinoma progression and immune evasion: insights from the tumor-mimetic ECM system.
BMC Cancer. 2025;26:8.
PubMed Abstract available

WANG Y, Yu F, Qiu F, Fang K, et al
Global burden of respiratory system cancers in 2022 and 2050: incidence and mortality estimates from GLOBOCAN.
BMC Cancer. 2025;25:1832.
PubMed Abstract available

KNIPPER K, Bruns CJ, Popp FC, Schmidt T, et al
MDM2-amplified esophageal adenocarcinomas exhibit an activated metabolic and immunosuppressive phenotype with multiple potential therapeutic targets.
BMC Cancer. 2025;25:1863.
PubMed Abstract available

HE J, Du C, Hu M, Zhang J, et al
Distinguishing benign from malignant thyroid nodules via virtual biopsy: a study on using quantitative parameters and classical radiomics features from dual-energy CT imaging.
BMC Cancer. 2025;25:1823.
PubMed Abstract available

WANG J, Zhang W, Li H, Wang Y, et al
Cell-free DNA methylation and fragmentomics-based liquid biopsy for accurate esophageal cancer detection.
BMC Cancer. 2025;25:1816.
PubMed Abstract available

LIU X, Shang Z, Gao J, Jiang N, et al
PD-1/PD-L1 inhibitors for locally advanced nasopharyngeal carcinoma: a systematic review and meta-analysis based on randomized controlled trials.
BMC Cancer. 2025 Nov 25. doi: 10.1186/s12885-025-15229.
PubMed

QI P, Huo S, Wu W, Zhang T, et al
MIR4435-2HG: a key player in the novel lncRNA prognostic signatures causes early metastasis after tumor resection and poor prognosis for esophageal squamous cell carcinoma.
BMC Cancer. 2025 Nov 24. doi: 10.1186/s12885-025-15299.
PubMed Abstract available

FELLER G, Mmereki D, Mahomed F, Khammissa RA, et al
Demographic, clinicopathological, and treatment of oral squamous cell carcinoma patients at a Johannesburg Academic Hospital, South Africa: a 5-year retrospective observational study.
BMC Cancer. 2025;25:1917.
PubMed Abstract available

CUI L, Yao N, Qin Z, Qin Q, et al
Consolidative thoracic radiotherapy improves the prognosis of metastatic esophageal cancer in the chemoimmunotherapy era: a propensity score matching study.
BMC Cancer. 2025;25:1775.
PubMed Abstract available

EROGLU I, Mohring C, Sadeghlar F, Manczak A, et al
Efficacy and safety of neoadjuvant FLOT treatment for resectable gastric/gastroesophageal junction adenocarcinoma in Turkish and German patients; a real-world data.
BMC Cancer. 2025;25:1754.
PubMed Abstract available

YANG P, Liu S, Chen X, Xin H, et al
Muscle-specific MRI grading of soft tissue involvement provides additional prognostic value beyond skull base criteria in nasopharyngeal carcinoma: a retrospective study.
BMC Cancer. 2025;25:1751.
PubMed Abstract available

PENG Y, Huang K, Gong Z, Liu W, et al
Nonenhanced CT-Based radiomics model enhances PTC detection in Hashimoto's thyroiditis.
BMC Cancer. 2025;25:1760.
PubMed Abstract available

WANG J, Cui Z, Yang K, Zhang Y, et al
Research on the expression, prognostic value, and regulatory effects on immune microenvironment of NETO2 in oral squamous cell carcinoma.
BMC Cancer. 2025;25:1714.
PubMed Abstract available

SUN Q, Liu R, Zhang H, Zong L, et al
Lipidomic and transcriptomic analysis and its therapeutic implications in Chinese Kazakh patients with esophageal squamous cell carcinoma.
BMC Cancer. 2025;25:1696.
PubMed Abstract available

GOU J, Hu Z, Cai M, Zhang S, et al
Microbial biomarkers and sex-associated gut microbiota characteristics of thyroid cancer.
BMC Cancer. 2025;25:1688.
PubMed Abstract available

October 2025

WEI H, Yuan L, Li Y, Xia Y, et al
Global status and attributable risk factors of esophageal, stomach, colorectal cancers in adolescents and young adults: global burden of disease 2021 study analysis.
BMC Cancer. 2025;25:1682.
PubMed Abstract available

NGUYEN TD, Nguyen HT, Huynh CG, Thai TT, et al
Expression of CD73 and VEGF in salivary gland carcinomas: associations with clinicopathological characteristics in Vietnamese population.
BMC Cancer. 2025;25:1678.
PubMed Abstract available

LYU Q, Chai Y, Chen W, Chen Y, et al
Integrated bioinformatics analysis of differences between EAC and ESCC.
BMC Cancer. 2025;25:1668.
PubMed Abstract available

HAJIMOKHTARI H, Soleymanpourshamsi T, Rostamian L, Yousefbeigi A, et al
Application of artificial intelligence in head and neck tumor segmentation: a comparative systematic review and meta-analysis between PET and PET/CT modalities.
BMC Cancer. 2025;25:1656.
PubMed Abstract available

LYU S, Wang Y, Chai F, Zhang J, et al
Full-length transcriptome analysis of papillary thyroid carcinoma reveals correlation between LAMB3 expression and clinical features.
BMC Cancer. 2025;25:1646.
PubMed Abstract available

BILGIC S, Nazari A, Sager MS, Sonmezoglu K, et al
Anatomical-biochemical discordance and prognostic role of bone metastases in advanced MTC treated with [(1)(7)(7)Lu]Lu-DOTA-TATE.
BMC Cancer. 2025;25:1644.
PubMed Abstract available

CHEN Y, Zhang Y, Wang X, Hong Y, et al
Assessment of radiation dermatitis in locally advanced head and neck cancer patients treated with concurrent chemoradiotherapy using LENT-SOMA scale: hematological indicators-based nomogram model.
BMC Cancer. 2025;25:1630.
PubMed

WANG G, Feng F, Huang S, Li C, et al
Clinical outcomes by bone metastasis uptake pattern in differentiated thyroid cancer.
BMC Cancer. 2025;25:1617.
PubMed Abstract available

KYEI KA, Daniels J, Degefu TT, Nyantakyi AY, et al
Nasopharyngeal carcinoma in sub-Saharan Africa: clinicopathological profiles, patterns of care, and survival outcomes of patients treated at a leading radiotherapy center.
BMC Cancer. 2025;25:1607.
PubMed Abstract available

N C S, Roberts TS, Opperman JF, Grobbelaar J, et al
Impact of thyroid dysfunction on clinical outcome in head and neck cancer: a systematic review and meta-analysis.
BMC Cancer. 2025;25:1605.
PubMed Abstract available

WU L, Pan C, Wang W, Gao Y, et al
Peripheral circulating proteomic profiling reveals serum CD80 is positively correlated with the efficacy of neoadjuvant PD-1 blockade combined with chemotherapy for esophagus cancer.
BMC Cancer. 2025;25:1608.
PubMed Abstract available

MA H, Wei W, Zhang J, Liang L, et al
Multi-channel deep learning radiomics model based on contrast-enhanced CT for predicting postoperative prognosis in laryngeal carcinoma.
BMC Cancer. 2025;25:1597.
PubMed Abstract available

ABOOSHAHAB R, Zarkesh M, Hedayati M
Metabolomics fingerprinting of thyroid malignancies: a GC/MS-based approach for subtype classification and biomarker discovery.
BMC Cancer. 2025;25:1586.
PubMed Abstract available

LIU X, Luo X, Xian Y, Ying L, et al
Fertility, gonadal and sexual function in survivors of nasopharyngeal carcinoma patients.
BMC Cancer. 2025;25:1583.
PubMed Abstract available

XIE R, Tang X, Lin T, Xiao G, et al
The occurrence of hyperthyroidism after thermal ablation for thyroid papillary carcinoma: a retrospective multicentre observational study.
BMC Cancer. 2025;25:1587.
PubMed Abstract available

MENG S, Lv A, Li N, Ding X, et al
Global, regional, and national burden of lip and oral cavity cancer and projections to 2036.
BMC Cancer. 2025;25:1573.
PubMed Abstract available

GU F, Wu E, Yan X, Huang W, et al
AHSA1 as a prognostic biomarker and potential immunotherapeutic target in HNSCC: integrative bulk RNA-seq, scRNA-seq analyses and experimental validation.
BMC Cancer. 2025;25:1560.
PubMed Abstract available

JANG HB, Kim SA, Jung EK, Lee KH, et al
SOX4 enhances tumor progression and cisplatin resistance in orthotopic mouse xenograft model of head and neck squamous cell carcinoma.
BMC Cancer. 2025;25:1570.
PubMed Abstract available

GROVER P, Tang C, Jacques A, Kernutt E, et al
A two-phase study investigating the quality of life benefit of additional 0.5% cocaine mouthwash to institutional standard of care mucositis management in head and neck cancer patients undergoing radiotherapy or chemoradiotherapy.
BMC Cancer. 2025;25:1551.
PubMed Abstract available

YU CT, Gao Y, Liu RY, Ding YA, et al
Prognostic and clinicopathological significance of tertiary lymphoid structure in esophageal squamous cell carcinoma: a systematic review and meta-analysis review.
BMC Cancer. 2025;25:1544.
PubMed Abstract available

SIM LC, Kuo YZ, Cheng TC, Chen CL, et al
Targeting the HIF1A-UCA1-PTBP3 axis: a potential therapeutic strategy for head and neck cancer.
BMC Cancer. 2025;25:1536.
PubMed

DONDERS DNV, Heldens GTN, Tellman RS, Takes RP, et al
Magnetic sentinel lymph node detection using superparamagnetic iron oxide in early-stage oral squamous cell carcinoma: design and rationale of the multicenter magnetics trial - study protocol.
BMC Cancer. 2025;25:1539.
PubMed Abstract available

YAN X, Peng Q, Chen J, Zhang R, et al
A nomogram based on conventional and contrast-enhanced ultrasound for predicting high-volume central lymph node metastasis in papillary thyroid carcinoma.
BMC Cancer. 2025;25:1529.
PubMed Abstract available

GOKMEN I, Sen E
Vismodegib treatment in locally advanced basal cell carcinoma limited to the facial region: a single-center experience.
BMC Cancer. 2025;25:1514.
PubMed Abstract available

LIU Y, He W, Wu Q, Ji JF, et al
Establishment of a Chinese library of patient-derived xenografts from gastrointestinal cancers.
BMC Cancer. 2025;25:1508.
PubMed Abstract available

LU X, Zhu L, Tan B, Liang Z, et al
Early circulating EBV-DNA clearance predicts enhanced short-term treatment response and survival benefit in locally advanced nasopharyngeal carcinoma.
BMC Cancer. 2025;25:1499.
PubMed Abstract available

YU D, Li F, Xu L, Xia X, et al
Efficacy of local radiotherapy in first-line treatment of recurrent or metastatic esophageal squamous cell carcinoma based on immunotherapy.
BMC Cancer. 2025;25:1484.
PubMed Abstract available

September 2025

ZHOU Y, Xiao M, Li J, Yang H, et al
Enhanced prognosis prediction model in esophageal cancer via lymph node assessment post-neoadjuvant.
BMC Cancer. 2025;25:1468.
PubMed Abstract available

BANDALA-JACQUES A, Saldanha IJ, D'Souza G
Oropharyngeal cancer risk groups in the United States: a meta-analysis and SEER analysis.
BMC Cancer. 2025;25:1441.
PubMed Abstract available

BOLEK H, Kayaalp M, Sahin TK, Dogan OT, et al
Real-world treatment patterns and survival outcomes in metastatic head and neck adenoid cystic carcinoma.
BMC Cancer. 2025;25:1451.
PubMed Abstract available

PAUL R, Sinharay S, Dhar D, Sarkar P, et al
A signature of correlated CDC20 and UBCH10 expression indicates poor prognosis in primary head and neck squamous cell carcinoma.
BMC Cancer. 2025;25:1458.
PubMed Abstract available

WEN K, Huang ZR, Liu YL, Wu WB, et al
Predictive value of nasopharyngeal microbiota for necrosis after re-irradiation in recurrent nasopharyngeal carcinoma.
BMC Cancer. 2025;25:1436.
PubMed Abstract available

YAO W, Dong S, Xu P, Zhong Z, et al
A subgroup analysis of locally advanced nasopharyngeal carcinoma patients with small lymph nodes and large nodes using adaptive radiotherapy.
BMC Cancer. 2025;25:1414.
PubMed Abstract available

MALTSEVA M, Klasen C, Wuerdemann N, Hannich M, et al
Detection and natural history of HPV infection of oral cavity and tonsils - a systematic literature review.
BMC Cancer. 2025;25:1405.
PubMed Abstract available

August 2025

LIU W, Ge D, Wang T, Zhao M, et al
Salvage involved-field versus extended-field chemoradiotherapy for postoperative lymph node metastasis in esophageal squamous cell carcinoma: a retrospective clinical study.
BMC Cancer. 2025;25:1390.
PubMed Abstract available

ZHANG H, Zhang B, Jiang Q, Wu B, et al
Radical surgery versus definitive radiotherapy in treatment of locoregional upper esophageal squamous cell carcinoma.
BMC Cancer. 2025;25:1382.
PubMed Abstract available

ANGUERA G, Gallego O, Llobet M, Berga N, et al
Opening of a phase Ib/II study to investigate the safety and efficacy of Afatinib in patients with Fanconi anemia and unresectable locally advanced or metastatic head and neck squamous cell carcinoma.
BMC Cancer. 2025;25:1374.
PubMed Abstract available

WU H, Shu W, Ding Y, Li Q, et al
The immune signatures predict gastric/gastroesophageal junction cancer response to first-line anti-PD-1 blockade or chemotherapy.
BMC Cancer. 2025;25:1369.
PubMed Abstract available

JEONG HJ, Lee JS, Lee JS, Yun HJ, et al
Anti-thyroglobulin antibody levels post-thyroidectomy and papillary thyroid carcinoma recurrence.
BMC Cancer. 2025;25:1371.
PubMed Abstract available

TAN C, Li Y, Jiang C, He L, et al
DWI-guided DP-IMRT and conventional MRI-based IMRT in head and neck squamous cell carcinoma: a comparative study.
BMC Cancer. 2025;25:1364.
PubMed Abstract available

LU Z, Zhu B, Ling H, Chen X, et al
Deep learning radiomics based on MRI for differentiating tongue cancer T - staging.
BMC Cancer. 2025;25:1358.
PubMed Abstract available

YANG Q, Zhou X, Li J, Wang J, et al
Comparative analysis and optimization of tumor regression grade assessment systems in neoadjuvant therapy for esophageal squamous cell carcinoma.
BMC Cancer. 2025;25:1341.
PubMed Abstract available

MAO Y, Gao Z, Sun Y, Shao C, et al
Four-year follow-up from the phase 2 study TD-NICE: neoadjuvant treatment of tislelizumab combined with chemotherapy in resectable esophageal squamous cell carcinoma.
BMC Cancer. 2025;25:1328.
PubMed Abstract available

NAWAB F, Naeem W, Fatima S, Ali A, et al
Exploring the mutational spectrum of key kinase genes PIK3CA, BRAF, EGFR, ALK and ROS1 in oral squamous cell carcinoma.
BMC Cancer. 2025;25:1333.
PubMed Abstract available

LIU L, Liu J, Rong Y, Zhang S, et al
Comparative study of neoadjuvant chemoradiotherapy, chemotherapy, and chemoimmunotherapy for locally advanced esophageal squamous cell carcinoma.
BMC Cancer. 2025;25:1320.
PubMed Abstract available

LIU Y, Han B
Global, regional, and national burden trends of lip and oral cavity cancer among individuals aged 60 and above from 1990 to 2021: a systematic analysis based on the 2021 global burden of disease data.
BMC Cancer. 2025;25:1322.
PubMed Abstract available

PANG F, Wu L, Qiu J, Guo Y, et al
Machine learning models for diagnosing lymph node recurrence in postoperative PTC patients: a radiomic analysis.
BMC Cancer. 2025;25:1308.
PubMed Abstract available

YUAN J, Gu J, Ding M, Jin X, et al
Protection of parathyroid function during thyroid surgery with a complete intermediate approach: a retrospective multicenter observational study.
BMC Cancer. 2025;25:1309.
PubMed Abstract available

LIN X, Liu S, Ding Y, Zhao J, et al
Contrasting tracheal, bronchus, and lung cancer burdens and care quality: a comparative analysis of China and global trends.
BMC Cancer. 2025;25:1298.
PubMed Abstract available

EMERICK C, Silva LC, Jang Y, Vargas PA, et al
Assessing the selective impact of histone modifying drugs on adenoid cystic carcinoma cells and their stem cell counterparts.
BMC Cancer. 2025;25:1277.
PubMed Abstract available

DONA MG, Paolini F, Benevolo M, Rollo F, et al
Detection and significance of HPV16 E5-specific productive transcripts in oropharyngeal carcinoma.
BMC Cancer. 2025;25:1274.
PubMed Abstract available

MCLAUGHLIN RA, McMahon D, Cluxton C, Fitzpatrick OM, et al
Neoadjuvant chemoradiation in older Irish adult patients with oesophageal cancer: a retrospective institutional review of clinical outcomes and hematological toxicity.
BMC Cancer. 2025;25:1280.
PubMed Abstract available

LIU J, Duan Y, Wang Y, Li X, et al
Novel prediction nomogram model for recurrent/persistent disease versus the American thyroid association recurrence risk stratification in patients with N1b papillary thyroid cancer: a retrospective cohort study.
BMC Cancer. 2025;25:1271.
PubMed Abstract available

GUO LF, Yu YF, Lu ZZ, Lin Q, et al
Two or three cycles of induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma?
BMC Cancer. 2025;25:1268.
PubMed Abstract available

CHEN J, Miao C, Wang X, Yang L, et al
Neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma: a clinical retrospective study.
BMC Cancer. 2025;25:1270.
PubMed Abstract available

LIU Q, Hu J, Liu L, He W, et al
Development of a nomogram based on body composition and tumor burden indicators to predict lymph node metastasis in patients with T1 esophageal squamous cell carcinoma.
BMC Cancer. 2025;25:1266.
PubMed Abstract available

WHANG SN, Rodarte V, Lohman T, Barforough J, et al
30-hydroxygambogic acid increases the efficacy of cisplatin in an HPV(+) head and neck cancer in vivo model.
BMC Cancer. 2025;25:1251.
PubMed

ZHONG W, Liu J, Xie J, Zhang Z, et al
Integrative analysis of saliva-derived exosomal proteome and lipidome for the diagnosis of esophageal squamous cell carcinoma.
BMC Cancer. 2025;25:1254.
PubMed Abstract available

ZHANG Q, Huang W, Chen X, Yan Z, et al
Watch-and-wait strategy in patients with objective response after immuno-chemotherapy for locally recurrent nasopharyngeal carcinoma: a pilot study.
BMC Cancer. 2025;25:1255.
PubMed Abstract available

July 2025

CUI T, Chen H, Fan M, Huang W, et al
Identifying risk factors and evaluating therapeutic interventions for anastomotic recurrence in postoperative esophageal squamous cell carcinoma.
BMC Cancer. 2025;25:1245.
PubMed Abstract available

LI Y, Zhang Y, Tang R, Gu A, et al
Clinical benefits of enhanced 3D-NEVERview sequence in MRI simulation for nasopharyngeal carcinoma patients received radiotherapy.
BMC Cancer. 2025;25:1232.
PubMed Abstract available

HOESSEINI A, Dronkers EAC, Dieleman E, De Herdt MJ, et al
Correction: Rotterdam Oncology Documentation (RONCDOC) - a high-quality data warehouse and tissue collection for head and neck cancer.
BMC Cancer. 2025;25:1213.
PubMed

NING ZK, Yi H, Yang T, Liu J, et al
Single-cell perspective on the Monocyte-to-HDL cholesterol ratio as a metastasis biomarker in papillary thyroid cancer.
BMC Cancer. 2025;25:1203.
PubMed Abstract available

WU M, Fang J, Zhang T
The expression and clinical significance of IL-27 and Foxp3 in oral squamous cell carcinoma.
BMC Cancer. 2025;25:1199.
PubMed Abstract available

LI WC, Ni WQ, Zhang YL, Lin YM, et al
Integrating pan-immune-inflammation value into personalized survival prediction of nasopharyngeal carcinoma: a large-scale long-term retrospective study.
BMC Cancer. 2025;25:1194.
PubMed Abstract available

GUO D, Chen C, Zheng Y, Shan Y, et al
Ultrasound feature-based nomogram model for predicting extrathyroidal extension in papillary thyroid carcinoma.
BMC Cancer. 2025;25:1185.
PubMed Abstract available

QIN ZH, Chen SY, Zhou S, Deng H, et al
Nasopharyngeal carcinoma detected noninvasively in the real world using three gene methylation analyses from automatically processed bilateral nasal swab samples.
BMC Cancer. 2025;25:1147.
PubMed Abstract available

GUO D, Du W, Yuan J, Zhao X, et al
Midline surpassing distance influences contralateral lymph node metastasis in cN0 tongue squamous cell carcinoma.
BMC Cancer. 2025;25:1138.
PubMed Abstract available

LI K, Yang Q, Wang Y, Zhang T, et al
Comparison of double-layered scallop-shaped anastomosis and circular stapled anastomosis in Ivor-Lewis surgery for esophageal and EGJ cancer: a retrospective cohort study.
BMC Cancer. 2025;25:1035.
PubMed Abstract available

CHEN C, Wang J, Li Y
A nomogram model to predict postoperative delirium in esophageal cancer patients undergoing esophagectomy.
BMC Cancer. 2025;25:1082.
PubMed Abstract available

WANG W, Song Y, Liu S, Xiong X, et al
Overexpression of KRAS enhanced the stemness of esophageal cancer cells inhibited by overexpression of circ0043898.
BMC Cancer. 2025;25:1039.
PubMed Abstract available

FAN X, Wang S, Li W, Meng K, et al
Assessment of intra-fractional and inter-fractional motion in esophageal cancer treated with intensity-modulated proton therapy.
BMC Cancer. 2025;25:1112.
PubMed Abstract available

WU J, Qin Y, Li K, Hao W, et al
Recurrence patterns and long-term survival of locally advanced esophageal cancer patients with pathological complete response after different neoadjuvant therapies followed by surgery.
BMC Cancer. 2025;25:1135.
PubMed Abstract available

SUN HB, Feng SK, Liu XB, Xing WQ, et al
Evaluating the efficacy of adjuvant chemotherapy in cT1b-T2 patients with incidentally discovered positive lymph nodes after esophagectomy for esophageal squamous cell carcinoma: a retrospective cohort study.
BMC Cancer. 2025;25:1060.
PubMed Abstract available

LI XQ, Lin DF, Cai YC, Xie SH, et al
Diagnostic performance of EBV DNA load testing for nasopharyngeal carcinoma in nasopharyngeal swab outperforms the approach in other specimens.
BMC Cancer. 2025;25:1126.
PubMed Abstract available

JIANG QL, Wang FY, Men Y, Wu YH, et al
Characteristic expression profile of small nucleolar RNAs and their association with tumor immune microenvironment in papillary thyroid carcinoma.
BMC Cancer. 2025;25:1073.
PubMed Abstract available

SONG Z, Liu Q, Huang J, Zhang D, et al
The value of machine learning based on spectral CT quantitative parameters in the distinguishing benign from malignant thyroid micro-nodules.
BMC Cancer. 2025;25:1041.
PubMed Abstract available

CHO YB, Park KS
Increased risk of nonalcoholic fatty liver disease in patients with thyroid cancer: a nationwide cohort study.
BMC Cancer. 2025;25:1093.
PubMed Abstract available

PASVENSKAITE A, Vilkeviciute A, Duseikaite M, Pileckaite E, et al
VEGFA (rs1570360, rs699947, rs3025033, rs2146323, rs3024997) genotypes in patients with laryngeal squamous cell carcinoma.
BMC Cancer. 2025;25:1132.
PubMed Abstract available

LU CH, Yin XL, Huang ZD, Lv SA, et al
Bioinformatics identification and validation of m6A/m1A/m5C/m7G/ac4 C-modified genes in oral squamous cell carcinoma.
BMC Cancer. 2025;25:1055.
PubMed Abstract available

ZHANG K, Zhang G, Qiao Y, Zhang P, et al
Comparison of single-port inflatable mediastinoscopic esophagectomy and thoracoscopic esophagectomy in patients with esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy.
BMC Cancer. 2025;25:1110.
PubMed Abstract available

June 2025

ALKA HH, Amol G, Archana S, Swati KP, et al
Correlation of clinical presentation with prognosis in oral squamous cell carcinoma associated with oral submucous fibrosis.
BMC Cancer. 2025;25:1000.
PubMed Abstract available

WU YY, Lee LC, Zeng H, Gu Y, et al
Synergistic effects of PD-1 antibody and chemotherapy followed by surgery-centric local treatment in patients with limited-metastatic gastric or gastroesophageal adenocarcinoma (ROSETTE trial): an open-label, single-center, randomized phase 2 trial.
BMC Cancer. 2025;25:981.
PubMed Abstract available

YANG X, Dou F, Tang G, Xiu R, et al
Interpretable machine learning model for predicting anastomotic leak after esophageal cancer surgery via LightGBM.
BMC Cancer. 2025;25:976.
PubMed Abstract available

May 2025

YU Y, Yan J
NAT10 inhibits the pyroptosis of laryngeal squamous cell carcinoma through ac4C modification of ELANE mRNA.
BMC Cancer. 2025;25:970.
PubMed Abstract available

PAN Y, Yang H, Zhang J, Zhang R, et al
CircSLC22A3 inhibits the invasion and metastasis of ESCC via the miR-19b-3p/TRAK2 axis and by reducing the stability of m(6)A-modified ACSBG1 mRNA.
BMC Cancer. 2025;25:971.
PubMed Abstract available

XING H, Wu C, Yang W, Cai S, et al
Tracheal, bronchus, and lung cancer among older adults: thirty-year global burden trends, precision medicine breakthroughs, and lingering barriers.
BMC Cancer. 2025;25:954.
PubMed Abstract available

GONG H, Jiang T, Yang Y, Jiang Y, et al
Short-term impact of delayed surgical treatment on the prognosis of patients with T1bN1-stage PTC: a retrospective cohort study.
BMC Cancer. 2025;25:950.
PubMed Abstract available

SUN N, Liu M, Xi C, Luo Q, et al
Comparison of efficacy and prognostic impact of adjuvant (131)I therapy at 3.7 GBq and 5.55 GBq in DTC patients with unexplained sTg elevation.
BMC Cancer. 2025;25:912.
PubMed Abstract available

SPRAVE T, Sahlmann J, Thomsen AR, Klein D, et al
Does severe mucositis impair oncological outcome in head and neck cancer patients? A pooled analysis of two prospective studies with long-term follow-up.
BMC Cancer. 2025;25:909.
PubMed Abstract available

WANG W, Wang H, Liu X, Xu F, et al
E2F2(E2F transcription factor 2) as a potential therapeutic target in meibomian gland carcinoma: evidence from functional and epigenetic studies.
BMC Cancer. 2025;25:880.
PubMed Abstract available

LIU M, Liao H, Peng Q, Huang J, et al
Comprehensive network pharmacology and experimentation to unveil the therapeutic efficacy and mechanisms of gypenoside LI in anaplastic thyroid cancer.
BMC Cancer. 2025;25:870.
PubMed Abstract available

HU X, Han C, Zhang M, Jia J, et al
Detecting radiation esophagitis using (18)F-FAPI-04 PET/CT in patients with LA-ESCC treated with concurrent chemoradiotherapy.
BMC Cancer. 2025;25:854.
PubMed Abstract available

ZHAO S, Zhang Y, Meng X, Wang Y, et al
INHBA(+) macrophages and Pro-inflammatory CAFs are associated with distinctive immunosuppressive tumor microenvironment in submucous Fibrosis-Derived oral squamous cell carcinoma.
BMC Cancer. 2025;25:857.
PubMed Abstract available

WU S, Luo H, Chen W, Liu X, et al
Camrelizumab combined with apatinib plus irinotecan as a second-line treatment in advanced or metastatic esophageal squamous cell carcinoma patients.
BMC Cancer. 2025;25:845.
PubMed Abstract available

YARAHMADI HB, Shahryari K, Bozorgi M, Shirdel A, et al
Dietary inflammatory index and the risk of esophageal cancer: a systematic review and meta-analysis.
BMC Cancer. 2025;25:826.
PubMed Abstract available

NAVRAN A, Gouw ZAR, Klop WM, Schreuder WH, et al
Postoperative complications following salvage neck dissection after (chemo)radiotherapy for head and neck squamous cell carcinoma: which patients are at high risk?
BMC Cancer. 2025;25:823.
PubMed Abstract available

CUI H, Li Z, Liu Y, Yang Y, et al
Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels the molecular feature of tumor-associated neutrophils of head and neck squamous cell carcinoma.
BMC Cancer. 2025;25:821.
PubMed Abstract available

WANG Q, Li Z, Zhang J, Zhang S, et al
Biomarkers of microvascularture by ultra Micro-angiography (UMA) assist to identify papillary thyroid carcinoma (PTC) with atypia of undetermined significance.
BMC Cancer. 2025;25:819.
PubMed Abstract available

SHAN F, Wang L, Lu X, Zhou M, et al
Integrating transcriptomic and metabolomic analyses to characterize the potential function of SLC1A5 in thyroid cancer.
BMC Cancer. 2025;25:817.
PubMed Abstract available

CHEN SH, Yu BY, Kuo WY, Lin YB, et al
Unveiling the immune microenvironment of complex tissues and tumors in transcriptomics through a deconvolution approach.
BMC Cancer. 2025;25.
PubMed Abstract available

April 2025

ZHANG JW, Gao XL, Wang J, Fan XL, et al
Comprehensive analysis illustrating the role of HOXB8 in head and neck squamous cell carcinoma: evidence from multi-omics analysis and experiments validation.
BMC Cancer. 2025;25:804.
PubMed Abstract available

ZHANG X, Li J, Gao M, Zhang Y, et al
Correlation between EpCAM expression and cervical lymph node metastasis in papillary thyroid carcinoma: a study integrating ultrasonographic features.
BMC Cancer. 2025;25:803.
PubMed Abstract available

TAN R, Zhu Y, Chen Z, Feng X, et al
Clinical correlation and survival analysis of hepatitis B virus infection in oral squamous cell carcinoma: a retrospective study of 1373 patients.
BMC Cancer. 2025;25:801.
PubMed Abstract available

YANG XL, Lin L, He SS, Wen DW, et al
Nasopharyngeal necrosis following intensity-modulated radiation therapy of primary nasopharyngeal carcinoma-incidence rate and predictors of risk.
BMC Cancer. 2025;25:802.
PubMed Abstract available

ZHANG X, Wang Z, Zhao Y, Ye H, et al
Multi-omics analysis unveils a four-gene prognostic signature in esophageal squamous carcinoma and the therapeutic potential of PKP1.
BMC Cancer. 2025;25:777.
PubMed Abstract available

HOESSEINI A, Dronkers EAC, Dieleman E, De Herdt MJ, et al
Rotterdam Oncology Documentation (RONCDOC) - a high-quality data warehouse and tissue collection for head and neck cancer.
BMC Cancer. 2025;25:778.
PubMed Abstract available

HADILOU M, Mahdavi N, Keykha E, Ghofrani A, et al
Artificial intelligence based vision transformer application for grading histopathological images of oral epithelial dysplasia: a step towards AI-driven diagnosis.
BMC Cancer. 2025;25:780.
PubMed Abstract available

CHEN X, Jiang Z, Pan J, Xu W, et al
Integrated multi-omics reveal lactate metabolism-related gene signatures and PYGL in predicting HNSCC prognosis and immunotherapy efficacy.
BMC Cancer. 2025;25:773.
PubMed Abstract available

XU XL, Wu CC, Cheng H
Prognostic significance of preoperative Naples prognostic score for disease-free and overall survival in oral cavity squamous cell carcinoma post-surgery.
BMC Cancer. 2025;25:757.
PubMed Abstract available

PANG KL, Li P, Yao XR, Xiao WT, et al
Deciphering a proliferation-essential gene signature based on CRISPR-Cas9 screening to predict prognosis and characterize the immune microenvironment in HNSCC.
BMC Cancer. 2025;25:756.
PubMed Abstract available

XU L, Wang B, Wang C, Mao N, et al
A model of basement membrane-related regulators for prediction of prognoses in esophageal cancer and verification in vitro.
BMC Cancer. 2025;25:696.
PubMed Abstract available

WANG X, Zhang W, Liang K, Wang Y, et al
Identification of m6 A-regulated ferroptosis biomarkers for prognosis in laryngeal cancer.
BMC Cancer. 2025;25:694.
PubMed Abstract available

XIE RL, Cai WL, Ouyang YF, Zou YH, et al
Effect and safety of immunotherapy among elder patients (age >/= 65) with recurrent or metastatic nasopharyngeal carcinoma.
BMC Cancer. 2025;25:691.
PubMed Abstract available

WANG J, Fu W, Luo J, Wei M, et al
Development of a clinical-molecular prediction model for central lymph node metastasis in cN0 stage papillary thyroid microcarcinoma: a retrospective study.
BMC Cancer. 2025;25:693.
PubMed Abstract available

LI P, Pang KL, Chen SJ, Yang D, et al
ADORA2B promotes proliferation and migration in head and neck squamous cell carcinoma and is associated with immune infiltration.
BMC Cancer. 2025;25:673.
PubMed Abstract available

XU X, Sun T, Zhang X, Wang W, et al
The predicting role of albumin to derived neutrophil-to-lymphocyte ratio for the prognosis of esophageal squamous cell carcinoma patients aged 60 years and above.
BMC Cancer. 2025;25:652.
PubMed Abstract available

TAMBA M, Osumi H, Ogura M, Fukuoka S, et al
Real-world safety and efficacy of neoadjuvant docetaxel, cisplatin, and 5-fluorouracil therapy for locally advanced esophageal squamous cell carcinoma.
BMC Cancer. 2025;25:636.
PubMed Abstract available

ZHANG W, Lu P, Li X, Fang Q, et al
Hypothyroidism following immunotherapy predicts more postoperative complication in oral squamous cell carcinoma.
BMC Cancer. 2025;25:643.
PubMed Abstract available

NASCA V, Bergamo F, Foltran L, Antonuzzo L, et al
Adjuvant TRastuzumab deruxtecan plus fluoropyrimidine versus standard chemotherapy in HER2-positive gastric or gastroesophageal cancer patients with persistence of minimal residual disease in liquid biopsy after pre-operative chemotherapy and radical
BMC Cancer. 2025;25:633.
PubMed Abstract available

TAN C, Li Y, Chen X, Zhu W, et al
Reirradiation based on diffusion-weighted magnetic resonance imaging-guided dose- painting for locally advanced recurrent nasopharyngeal carcinoma: a phase 2 randomized controlled trial.
BMC Cancer. 2025;25:622.
PubMed Abstract available

YANG K, Yue B, Tian H, Wang L, et al
Paeonol inhibits the Glycolysis in oral squamous cell carcinoma though suppressing NAT10-mediated ac(4)C modification.
BMC Cancer. 2025;25:629.
PubMed Abstract available

WEI K, Ma Y, Xu J, Zheng H, et al
Potential changes in microorganisms and metabolites associated with oral cancer: a preliminary study.
BMC Cancer. 2025;25:611.
PubMed Abstract available

YU N, Wan Y, Zuo L, Cao Y, et al
Multi-modal radiomics features to predict overall survival of locally advanced esophageal cancer after definitive chemoradiotherapy.
BMC Cancer. 2025;25:596.
PubMed Abstract available

PAN YX, Huang Q, Xing S, Zhu QY, et al
A novel serum protein biomarker for the late-stage diagnosis of nasopharyngeal carcinoma.
BMC Cancer. 2025;25:585.
PubMed Abstract available

HASIBUZZAMAN MM, He R, Khan IN, Salem AK, et al
Radiotherapy is enhanced by CPH:SA IL-1alpha microparticles in a murine HNSCC tumor model.
BMC Cancer. 2025;25:588.
PubMed Abstract available

GOLESTANNEJAD P, Monkaresi M, Zhian Zargaran F, Khosravani M, et al
Role of Cancer Associated Fibroblast (CAF) derived miRNAs on head and neck malignancies microenvironment: a systematic review.
BMC Cancer. 2025;25:582.
PubMed Abstract available

LIU S, Guan T, Yang F, Zhang H, et al
Targeting CD276: a promising strategy for CAR-NK cell immunotherapy in human oral tongue squamous cell carcinoma.
BMC Cancer. 2025;25:593.
PubMed Abstract available

March 2025

LI S, Yu Y, Xu Y, Zhou Y, et al
Clinicopathological characteristics and the relationship of PD-L1 status, tumor mutation burden, and microsatellite instability in patients with esophageal carcinoma.
BMC Cancer. 2025;25:576.
PubMed Abstract available

OUYANG H, Liu Y, He X, Zhang J, et al
A comparative study of different parameter estimation methods for predictive models of Normal Tissue Complication Probability (NTCP) of radiation-induced temporal lobe injury following intensity-modulated radiotherapy in nasopharyngeal carcinoma.
BMC Cancer. 2025;25:572.
PubMed Abstract available

YUKSEL IB, Bahrilli S, Altindag A
Turkish dental students' knowledge, attitudes, and awareness of oral cancer.
BMC Cancer. 2025;25:568.
PubMed Abstract available

BASTIT V, Lequesne J, Leconte A, Deneuve S, et al
Effectiveness of bilateral tongue base mucosectomy by transoral robotic surgery or transoral laser microsurgery in combination with tonsillectomy in identifying head and neck primary cancer of unknown primary: a randomized phase 2 protocol (RoboCUP tr
BMC Cancer. 2025;25:551.
PubMed Abstract available

YIN X, Luo M, Zha X, Duan M, et al
RBMS1-HSPA8 axis activation drives head and neck squamous cell carcinoma progression.
BMC Cancer. 2025;25:549.
PubMed Abstract available

XU Y, Xu M, Geng Z, Liu J, et al
Thyroid nodule classification in ultrasound imaging using deep transfer learning.
BMC Cancer. 2025;25:544.
PubMed Abstract available

JIAN L, Chen MK, Kor CT, Liu YT, et al
Influence of psoriasis on infection risk and survival outcomes in patients with head and neck cancer: a retrospective cohort study.
BMC Cancer. 2025;25:534.
PubMed Abstract available

JIAN L, Sheng C, Liu H, Li H, et al
Early prediction of progression-free survival of patients with locally advanced nasopharyngeal carcinoma using multi-parametric MRI radiomics.
BMC Cancer. 2025;25:519.
PubMed Abstract available

RAST J, Zebralla V, Wald T, Dietz A, et al
The impact of financial burden on quality of life among German head and neck cancer survivors.
BMC Cancer. 2025;25:514.
PubMed Abstract available

WANG L, Wang HM, Tang F, Zhang YT, et al
The impact of different cervical planning target volume designs on efficacy and toxicity in nasopharyngeal carcinoma: a single-center retrospective study.
BMC Cancer. 2025;25:485.
PubMed Abstract available

ZHAO J, Yang G, Li Y, Li S, et al
Predicting anastomotic leak in patients with esophageal squamous cell cancer treated with neoadjuvant chemoradiotherapy using a nomogram based on CT radiomic and clinicopathologic factors.
BMC Cancer. 2025;25:484.
PubMed Abstract available

CHEN Y, Hu R, Jin C, Huang L, et al
Pilot study of ultrasound-guided microwave ablation for inactivating excess remnant thyroid after surgery in patients with differentiated thyroid cancer.
BMC Cancer. 2025;25:469.
PubMed Abstract available

YIN Z, Zhang H, Zhang K, Yue J, et al
Impacts of combining PD-L1 inhibitor and radiotherapy on the tumour immune microenvironment in a mouse model of esophageal squamous cell carcinoma.
BMC Cancer. 2025;25:474.
PubMed Abstract available

SHAMSI U, Arshad MS, Rashid YA, Jehanzeb H, et al
Determinants of oral cavity cancer recurrence in Pakistan: findings from a cross-sectional study using an institutional cancer registry.
BMC Cancer. 2025;25:459.
PubMed Abstract available

HUANG Q, Hu J, Hu W, Gao J, et al
Clinical outcomes of particle beam radiation therapy for patients with newly-diagnosed major salivary gland tumors.
BMC Cancer. 2025;25:452.
PubMed Abstract available

RAY AD, Hong CC, Schlecht NF, Yu H, et al
Respiratory muscle training reduces painful swallowing and opioid use during radiation therapy for head and neck cancer: a matched pair analysis.
BMC Cancer. 2025;25:442.
PubMed Abstract available

XU W, Jiang H, Liu Y, Liu X, et al
A retrospective cohort study on radio/chemotherapy and survival following esophageal fistula in esophageal cancer patients with prior radiotherapy.
BMC Cancer. 2025;25:440.
PubMed Abstract available

YANG J, Zhu Y, Zhou Y, Zhang J, et al
Potential biomarkers develop for predicting the prognosis of patients with esophageal squamous cell carcinoma after optimized chemoradiotherapy using serum metabolomics.
BMC Cancer. 2025;25:438.
PubMed Abstract available

LOU P, Huang Y, Li H, Zhao F, et al
Predicting central lymph node metastasis in papillary thyroid carcinoma combined with Hashimoto's thyroiditis: a preoperative study.
BMC Cancer. 2025;25:425.
PubMed Abstract available

GOMES MCMF, Ferreira PMV, Almeida ACSM, Cornelio JS, et al
Dysphagia, nutritional status, and quality of life in patients with head and neck cancer undergoing radiotherapy alone or combined with chemotherapy: an observational study.
BMC Cancer. 2025;25:416.
PubMed Abstract available

LI Q, Pu G
SIRT7 affects the proliferation and apoptosis of papillary thyroid cancer cells by desuccinylation of LATS1.
BMC Cancer. 2025;25:408.
PubMed Abstract available

TANG H, Guo D, Yang B, Huang SH, et al
Location based BRAF V600E mutation status and dimension patterns of sporadic thyroid nodules: a population-based study.
BMC Cancer. 2025;25:406.
PubMed Abstract available

CHEN X, Song F, Xiao P, Yao Y, et al
Spermine accumulation via spermine synthase promotes tumor cell proliferation in head and neck squamous cell carcinoma.
BMC Cancer. 2025;25:402.
PubMed Abstract available

February 2025

WANG Y, Huang S, Huang R
Two or three weeks of thyroid hormone withdrawal before initial (131)I therapy for patients with differentiated thyroid carcinoma?
BMC Cancer. 2025;25:370.
PubMed Abstract available

ZHANG H, Li Y, Li L
Blood metabolites reflect the effect of gut microbiota on differentiated thyroid cancer: a Mendelian randomization analysis.
BMC Cancer. 2025;25:368.
PubMed Abstract available

TRAN KL, Turkdogan S, Dinur AB, Milner TD, et al
A multi-centre, participant-blinded, randomized, 3-year study to compare the efficacy of Virtual Surgical Planning (VSP) to Freehand Surgery (FHS) on bony union and quality of life outcomes for mandibular reconstruction with fibular and scapular free
BMC Cancer. 2025;25:358.
PubMed Abstract available

ALI A, Bari MF, Arshad S, Wahid M, et al
Tissue-resident memory T-cell expressions and their prognostic role in head and neck squamous cell carcinoma: a systematic review and meta-analysis.
BMC Cancer. 2025;25:356.
PubMed Abstract available

ZHANG K, Wang Q, Cao J, Fan C, et al
Tislelizumab plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy for elderly patients with inoperable locally advanced esophageal squamous cell carcinoma: a multicenter, randomized, parallel-controlled, phase II clinical trial.
BMC Cancer. 2025;25:347.
PubMed Abstract available

PARK YI, Choi SH, Cho MS, Son J, et al
The potential of thermal imaging as an early predictive biomarker of radiation dermatitis during radiotherapy for head and neck cancer: a prospective study.
BMC Cancer. 2025;25:309.
PubMed Abstract available

ZHOU T, Wang X, Zhu Q, Zhou E, et al
Global trends and risk factors of laryngeal cancer: a systematic analysis for the Global Burden of Disease Study (1990-2021).
BMC Cancer. 2025;25:296.
PubMed Abstract available

LI H, Liang S, Cui M, Jin W, et al
A preoperative pathological staging prediction model for esophageal cancer based on CT radiomics.
BMC Cancer. 2025;25:298.
PubMed Abstract available

SMUSSI D, Conti C, Lorini L, Mattavelli D, et al
Financial toxicity questionnaire (FIT): development and validation of the italian version (FITALY) in head and neck cancer patients undergoing multimodal curative treatment.
BMC Cancer. 2025;25:283.
PubMed Abstract available

YIN Y, Zhang W, Zou L, Liu X, et al
Segmentation methods and dosimetric evaluation of 3D-printed immobilization devices in head and neck radiotherapy.
BMC Cancer. 2025;25:289.
PubMed Abstract available

LIMA CR, Geraldo MV, Fuziwara CS, Kimura ET, et al
Correction: MiRNA-146b-5p upregulates migration and invasion of different papillary thyroid carcinoma cells.
BMC Cancer. 2025;25:256.
PubMed

ZHOU HD, Wei Y, Zhao ZL, Peng L, et al
A clinical study on microwave ablation of T1N0M0 papillary thyroid carcinoma locating in dangerous region.
BMC Cancer. 2025;25:240.
PubMed Abstract available

JIANG JL, Chang JT, Huang BS, Chang TY, et al
Post-irradiation vertebral and carotid stenosis heightens stroke risk in head and neck cancer.
BMC Cancer. 2025;25:235.
PubMed Abstract available

ZHAO J, Wang K, Li Y, Hu X, et al
Impact of radiation dose to immune cells on survival in patients with esophageal cancer receiving neoadjuvant chemoradiotherapy: a retrospective analysis.
BMC Cancer. 2025;25:238.
PubMed Abstract available

HUANG YC, Chen SW, Chiang YS
Prognostic role of geriatric nutritional risk index (GNRI) and controlling nutritional status (CONUT) on outcomes in patients with head and neck cancer: a systematic review and meta-analysis.
BMC Cancer. 2025;25:242.
PubMed Abstract available

DONG Y, Wang F, Deng J, Tong T, et al
Prognostic value of serum inflammatory markers in patients with esophageal squamous cell carcinoma undergoing surgery: a two-center retrospective cohort study.
BMC Cancer. 2025;25:213.
PubMed Abstract available

XU M, Wang L, Ding J, Xu Y, et al
The prognostic value of boost dose in residual cervical lymph nodes in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy: a retrospective study.
BMC Cancer. 2025;25:222.
PubMed Abstract available

LI Y, Cao Y, Wang X, Li C, et al
Effects of perioperative treatment of resectable adenocarcinoma of esophagogastric junction by immunotherapy (Adebrelimab) combined with chemotherapy (XELOX): protocol for a single-center, open-labeled study (AEGIS trial, neoadjuvant immunochemotherap
BMC Cancer. 2025;25:198.
PubMed Abstract available

FURUKAWA J, Kakei Y, Murakami S, Kita H, et al
Safety and efficacy of oral cancer vaccine B440 in patients with PD-1/PD-L1 inhibitor-resistant advanced urothelial cancer: a study protocol for a phase 1 multicenter, open-label, single-arm clinical trial.
BMC Cancer. 2025;25:195.
PubMed Abstract available

January 2025

CHENG KL, Lu HJ, Shen CY, Lin CW, et al
Intravoxel incoherent motion (IVIM) MRI-derived masseter muscle characteristics: a new diagnostic marker in head and neck cancer?
BMC Cancer. 2025;25:184.
PubMed Abstract available

WANG N, Chen Y, Lin J, Lin Y, et al
Identification of novel serum lipid metabolism potential markers and metabolic pathways for oral cancer: a population-based study.
BMC Cancer. 2025;25:177.
PubMed Abstract available

WANG Z, Yang Y, Ge C, Tian R, et al
Delineation of reduced CTV2 on the basis of the characteristics and distribution of cervical lymph node metastasis in nasopharyngeal carcinoma.
BMC Cancer. 2025;25:145.
PubMed Abstract available

WANG Z, Xiao Z, Zhang T, Lu M, et al
Development and validation of a novel artificial intelligence algorithm for precise prediction the postoperative prognosis of esophageal squamous cell carcinoma.
BMC Cancer. 2025;25:134.
PubMed Abstract available

HTET H, Anaghan JRJ, Jaiprakash H, Burud IAS, et al
Efficacy and safety of molecular targeted therapies in nasopharyngeal carcinoma: a network meta-analysis.
BMC Cancer. 2025;25:110.
PubMed Abstract available

LI X, Yao XY, Liu SR, Mei F, et al
Gross recurrent laryngeal nerve invasion by extranodal extension in thyroid carcinoma.
BMC Cancer. 2025;25:109.
PubMed Abstract available

CAO W, Jin D, Min W, Li H, et al
Prognostic values of intracellular cell-related genes in esophageal cancer and their regulatory mechanisms.
BMC Cancer. 2025;25:105.
PubMed Abstract available

WANG R, Guo T, Wang Q, Gao W, et al
The efficacy and safety of induction chemotherapy combined with sintilimab followed by concurrent chemoradiotherapy plus sintilimab sequencing maintaining with sintilimab for patients with unresectable locally advanced esophageal squamous cell carcino
BMC Cancer. 2025;25:97.
PubMed Abstract available

DENG L, Ran H, Yang D, Wang Z, et al
TOM40 as a prognostic oncogene for oral squamous cell carcinoma prognosis.
BMC Cancer. 2025;25:92.
PubMed Abstract available

YANG M, Zheng G, Chen F, Tang H, et al
Molecular characterization of EBV-associated primary pulmonary lymphoepithelial carcinoma by multiomics analysis.
BMC Cancer. 2025;25:85.
PubMed Abstract available

SOWELL FG, de Milliano T, Brady KJS, Foglia G, et al
A conceptual model for advanced/metastatic gastric or gastroesophageal junction cancer: a review of qualitative studies and results from patient interviews.
BMC Cancer. 2025;25:88.
PubMed Abstract available

HE L, Li L, Zhao L, Guan X, et al
CircCCT2/miR-146a-5p/IRAK1 axis promotes the development of head and neck squamous cell carcinoma.
BMC Cancer. 2025;25:84.
PubMed Abstract available

DUAN X, Yue J, Wang S, Zhao F, et al
Prognostic role of the pathological status following neoadjuvant chemoradiotherapy and surgery in esophageal squamous cell carcinoma.
BMC Cancer. 2025;25:61.
PubMed Abstract available

IITAKA S, Kuroda A, Narita T, Hatakeyama H, et al
Correction: Evaluation of N-NOSE as a surveillance tool for recurrence in gastric and esophageal cancers: a prospective cohort study.
BMC Cancer. 2025;25:54.
PubMed

PIKUL J, Machnicki MM, Rzepakowska A, Winiarska N, et al
Potentially actionable molecular alterations in particular related to poor oncologic outcomes in salivary gland carcinomas.
BMC Cancer. 2025;25:42.
PubMed Abstract available

XU Y, Lin C, Han C, Wang X, et al
Development of a prognostic nomogram and risk stratification system for elderly patients with esophageal squamous cell carcinoma undergoing definitive radiotherapy: a multicenter retrospective analysis (3JECROG R-03 A).
BMC Cancer. 2025;25:40.
PubMed Abstract available

HIKEN J, Earls J, Flanagan KC, Wellinghoff RL, et al
Analytical performance of OncoPrism-HNSCC, an RNA-based assay to inform immune checkpoint inhibitor treatment decisions for recurrent/metastatic head and neck squamous cell carcinoma.
BMC Cancer. 2025;25:21.
PubMed Abstract available

MATIKU S, Murenzi G, Rugengamanzi E, Liwa E, et al
Androgen receptor overexpression by immunohistochemistry in malignant salivary gland tumors in Tanzania.
BMC Cancer. 2025;25:29.
PubMed Abstract available

WANG J, Zhao L, Lin J, Yu Y, et al
Comparison of mediastinoscopy and thoracoscope minimally invasive esophagectomy in the treatment of esophageal cancer: a meta-analysis and system review.
BMC Cancer. 2025;25:14.
PubMed Abstract available

December 2024

LIU H, Zhang S, Liu X, Wang Q, et al
Thyroid cancer survival and prognostic factors in Yantai, China (2012-2022): a population-based study.
BMC Cancer. 2024;24:1587.
PubMed Abstract available

ZHENG Y, Xing W, BingWei, Liu X, et al
Detection of a novel DNA methylation marker panel for esophageal cancer diagnosis using circulating tumor DNA.
BMC Cancer. 2024;24:1578.
PubMed Abstract available

ALQAHTANI T, Alsubait A, Aloumi M, Alamer A, et al
A novel role for nonactin: interfering with G-quadruplex in RET-driven medullary thyroid cancer.
BMC Cancer. 2024;24:1569.
PubMed Abstract available

COURTNEY PT, L Santoso M, Savjani RR, K Reddy V, et al
A phase II study of personalized ultrafractionated stereotactic adaptive radiotherapy for palliative head and neck cancer treatment (PULS-Pal): a single-arm clinical trial protocol.
BMC Cancer. 2024;24:1564.
PubMed Abstract available

ALMANGUSH A, Alabi RO, Pirinen M, Makitie A, et al
Accumulating evidence from meta-analyses of prognostic studies on oral cancer: towards biomarker-driven patient selection.
BMC Cancer. 2024;24:1517.
PubMed Abstract available

JIANG C, Li J, Peng H, Zhou D, et al
The clinical target volume delineation based on the correlation analysis of neck node levels in oral cavity squamous cell carcinoma (OCSCC).
BMC Cancer. 2024;24:1530.
PubMed Abstract available

CHENG X, Meng F, Wang R, Liu S, et al
Prognostic value of immuno-inflammatory biomarkers in esophageal squamous cell carcinoma patients receiving immunotherapy combined with chemoradiotherapy and its association with immuno-genomic landscape.
BMC Cancer. 2024;24:1518.
PubMed Abstract available

JAVID M, Mirdamadi A, Javid M, Keivanlou MH, et al
The evolving role of MRI in the detection of extrathyroidal extension of papillary thyroid carcinoma: a systematic review and meta-analysis.
BMC Cancer. 2024;24:1531.
PubMed Abstract available

SCHMIDT M, Vernooij R, van Nuland M, Smeijsters E, et al
Impaired liver function: effect on paclitaxel toxicity, dose modifications and overall survival.
BMC Cancer. 2024;24:1553.
PubMed Abstract available

IITAKA S, Kuroda A, Narita T, Hatakeyama H, et al
Evaluation of N-NOSE as a surveillance tool for recurrence in gastric and esophageal cancers: a prospective cohort study.
BMC Cancer. 2024;24:1544.
PubMed Abstract available

ZENG S, Jiang K, Ge J, Tang M, et al
NTRK fusion promotes tumor migration and invasion through epithelial-mesenchymal transition and closely interacts with ECM1 and NOVA1.
BMC Cancer. 2024;24:1502.
PubMed Abstract available

WANG Y, Zhang H, Wang H, Hu Y, et al
Development of a neoadjuvant chemotherapy efficacy prediction model for nasopharyngeal carcinoma integrating magnetic resonance radiomics and pathomics: a multi-center retrospective study.
BMC Cancer. 2024;24:1501.
PubMed Abstract available

MUDIYANSELAGE SB, Nguyen D, Tang B, Williams R, et al
The epidemiological trends and predictions of esophageal squamous cell carcinoma and gastroesophageal junction carcinoma: an Australian population-based study.
BMC Cancer. 2024;24:1498.
PubMed Abstract available

TANG D, Cao C, Li W, Wang A, et al
FTO-mediated demethylation of MTUS1/ATIP1 promotes tumor progression in head and neck squamous cell carcinoma.
BMC Cancer. 2024;24:1489.
PubMed Abstract available

WANG S, Wang Y, Xu J, Ren Q, et al
Ultrasound characteristics of alveolar soft part sarcoma in pediatric patients: a retrospective analysis.
BMC Cancer. 2024;24:1484.
PubMed Abstract available

LIU L, Wang P, Guo C, Song L, et al
TRAIP enhances progression of tongue squamous cell carcinoma through EMT and Wnt/beta-catenin signaling by interacting with DDX39A.
BMC Cancer. 2024;24:1481.
PubMed Abstract available

November 2024

KASMANN L, Nieto A, Rennollet R, Gurtner R, et al
Validation of two predictive models for survival in anaplastic thyroid cancer (ATC).
BMC Cancer. 2024;24:1477.
PubMed Abstract available

ZHANG L, Wang S, Wang L
SKA1/2/3 is a prognostic and predictive biomarker in esophageal adenocarcinoma and squamous cell carcinoma.
BMC Cancer. 2024;24:1480.
PubMed Abstract available

XIE JB, Huang SJ, Yang TB, Wang W, et al
Comparison of machine learning methods for Predicting 3-Year survival in elderly esophageal squamous cancer patients based on oxidative stress.
BMC Cancer. 2024;24:1432.
PubMed Abstract available

YANG R, Li T, Zhang S, Shui C, et al
The effect of circulating tumor DNA on the prognosis of patients with head and neck squamous cell carcinoma: a systematic review and meta-analysis.
BMC Cancer. 2024;24:1434.
PubMed Abstract available

LI T, Dai Y, Fu X, Cai Q, et al
Prospective multicenter study of camrelizumab in real-world settings for asian patients with esophageal squamous cell carcinoma.
BMC Cancer. 2024;24:1421.
PubMed Abstract available

CAI M, Gou J
Symptoms and negative emotions in patients with advanced thyroid cancer: a prospective cross-sectional study.
BMC Cancer. 2024;24:1418.
PubMed Abstract available

GUO J, Si G, Song X, Si F, et al
Association of B cells and the risk of Esophageal cancer: a bidirectional two-sample mendelian randomization study.
BMC Cancer. 2024;24:1416.
PubMed Abstract available

ABOOSHAHAB R, Zarkesh M, Sameni M, Akbarzadeh M, et al
Expression of TSPAN1 and its link to thyroid nodules: one step forward on the path to thyroid tumorigenesis biomarkers.
BMC Cancer. 2024;24:1414.
PubMed Abstract available

PAN C, Ng K, Voutsinas J, Barber B, et al
Development of a prognostic signature for overall survival using peripheral blood biomarkers in head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.
BMC Cancer. 2024;24:1406.
PubMed Abstract available

ZHOU Y, Zhou J, Cai X, Ge S, et al
Integrating (18)F-FDG PET/CT radiomics and body composition for enhanced prognostic assessment in patients with esophageal cancer.
BMC Cancer. 2024;24:1402.
PubMed Abstract available

NIKKILA R, Hirvonen E, Haapaniemi A, Pitkaniemi J, et al
Second primary cancers in patients with a pharyngeal index tumour: a register-based cohort study.
BMC Cancer. 2024;24:1380.
PubMed Abstract available

YANG Y, Zhang J, Yuan C, Cheng Z, et al
Recurrent aphthous stomatitis and neoplasms of the mouth and pharynx: a two-sample Mendelian randomization study.
BMC Cancer. 2024;24:1372.
PubMed Abstract available

LI P, Zhang X, Fang Q, Du W, et al
Sentinel lymph node biopsy in cT1-2N0 minor salivary gland cancer in oral cavity.
BMC Cancer. 2024;24:1349.
PubMed Abstract available

October 2024

ZHANG Y, Xu W, Wu M, Li Y, et al
Survival risk stratification based on prognosis nomogram to identify patients with esophageal squamous cell carcinoma who may benefit from postoperative adjuvant therapy.
BMC Cancer. 2024;24:1330.
PubMed Abstract available

TSAI YT, Chen WC, Wen YW, Lin CY, et al
Prognostic significance of adjuvant therapy and specific radiation dosages in Taiwanese patients with oral cavity cancer and extra-nodal extension: a nationwide cohort study.
BMC Cancer. 2024;24:1320.
PubMed Abstract available

FU LL, Yan M, Yu X, Shao M, et al
Retinol-binding protein type 1 expression predicts poor prognosis in head and neck squamous cell carcinoma.
BMC Cancer. 2024;24:1277.
PubMed Abstract available

BILGIC S, Meral R, Sager MS, Sonmezoglu K, et al
RAI therapy in low-risk papillary thyroid cancer: recurrence reduction and long-term outcomes in the Turkish population.
BMC Cancer. 2024;24:1273.
PubMed Abstract available

ZHANG Y, Meng Z, Lu M, Ruan S, et al
Study of the significance of the combination of the fibrinogen-albumin ratio and sarcopenia in predicting the prognosis of laryngeal cancer patients undergoing radical surgery.
BMC Cancer. 2024;24:1265.
PubMed Abstract available

GHORBANPOUR M, Salarvand S, Salarvand S, Shahsavari F, et al
Depth of invasion and extranodal extension: the influential factors to predict survival rate of patients with oral tongue squamous cell carcinoma.
BMC Cancer. 2024;24:1256.
PubMed Abstract available

XIONG W, Xie Y, Wang D, Huang X, et al
Aldo-keto reductase family 1 member C3 mediates radioresistance of esophageal cancer cells through suppressing MAPK and AKT signaling.
BMC Cancer. 2024;24:1236.
PubMed Abstract available

THARIAT J, Pham TN, Coupey J, Clarisse B, et al
CYRAD: a translational study assessing immune response to radiotherapy by photons or protons in postoperative head and neck cancer patients through circulating leukocyte subpopulations and cytokine levels.
BMC Cancer. 2024;24:1230.
PubMed Abstract available

WANG Y, Ma K, Zhang H, Wu L, et al
Comparison of pathologic response and survival outcomes between neoadjuvant chemoradiotherapy (nCRT) and neoadjuvant immunochemotherapy (nICT) in patients with locally advanced esophageal squamous cell carcinoma: a propensity score-matched analysis.
BMC Cancer. 2024;24:1228.
PubMed Abstract available

YANG MH, Chen TH, Wang HM, Hsieh JC, et al
Prognostic factors and risk-stratification model of recurrent or metastatic head and neck squamous cell carcinoma treated with cetuximab containing regimen.
BMC Cancer. 2024;24:1227.
PubMed Abstract available

JIN J, Guo SS, Liu LT, Wen DX, et al
Comparison of long-term quality of life and their predictors in survivors between paediatric and adult nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.
BMC Cancer. 2024;24:1223.
PubMed Abstract available

RZEPAKOWSKA A, Oledzka J, Daniel P, Mekarska M, et al
Immunomodulatory role of tumor microenvironment on oncological outcomes in advanced laryngeal cancer.
BMC Cancer. 2024;24:1219.
PubMed Abstract available

September 2024

THEODORAKI MN, Huber D, Hofmann L, Werner L, et al
Type 2-like polarization and elevated CXCL4 secretion of monocyte derived macrophages upon internalization of plasma-derived exosomes from head and neck cancer patients.
BMC Cancer. 2024;24:1173.
PubMed Abstract available

WEIJERS JAM, Verhaegh GW, Lassche G, van Engen-van Grunsven ACH, et al
A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma - the DUCT study protocol.
BMC Cancer. 2024;24:1174.
PubMed Abstract available

DONG L, Li Y, Song X, Sun C, et al
SFRP1 mediates cancer-associated fibroblasts to suppress cancer cell proliferation and migration in head and neck squamous cell carcinoma.
BMC Cancer. 2024;24:1165.
PubMed Abstract available

YADAV J, Chaudhary A, Tripathi T, Janjua D, et al
Exosomal transcript cargo and functional correlation with HNSCC patients' survival.
BMC Cancer. 2024;24:1144.
PubMed Abstract available

ZHU Y, Xue F
Comparing long-term efficacy and safety of GP versus TPF sequential chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis.
BMC Cancer. 2024;24:1145.
PubMed Abstract available

CHEN J, Wang Y, Wu M, Yu K, et al
Vasculogenic mimicry triggers early recidivation and resistance to adjuvant therapy in esophageal cancer.
BMC Cancer. 2024;24:1132.
PubMed Abstract available

ZHANG SL, Wu ZY, Fan RX, Jia J, et al
Managing malignant sublingual gland tumors: a single institution experience with 23 patients.
BMC Cancer. 2024;24:1135.
PubMed Abstract available

DUAN W, Wu Z, Jiang H, Liao G, et al
Preoperative thromboelastography parameters in predicting the tumour stage of oral squamous cell carcinoma.
BMC Cancer. 2024;24:1136.
PubMed Abstract available

LIU H, Lei L, Song S, Geng X, et al
The serological diagnostic value of EBV-related IgA antibody panels for nasopharyngeal carcinoma: a diagnostic test accuracy meta-analysis.
BMC Cancer. 2024;24:1115.
PubMed Abstract available

KERSEN J, Roach P, Chandarana S, Ronksley P, et al
Exploring transitions in care among patients with head and neck CANCER: a multimethod study.
BMC Cancer. 2024;24:1108.
PubMed Abstract available

MACDONALD C, Fitch M, Hutcheson KA, McCulloch TM, et al
A protocol for stakeholder engagement in head and neck cancer pragmatic trials.
BMC Cancer. 2024;24:1109.
PubMed Abstract available

HUANG J, Yu Y, Wu Z, Wu C, et al
Thoracoscopic three-port single versus multiple intercostal for radical resection of esophageal cancer: a retrospective analysis.
BMC Cancer. 2024;24:1104.
PubMed Abstract available

YAO J, Zhao X, Chen J, Liu T, et al
Treatment strategies for elderly patients with locally advanced esophageal cancer: a systematic review and meta-analysis.
BMC Cancer. 2024;24:1101.
PubMed Abstract available

SHARMA S, Mittal M, Shukla A, Khan J, et al
Exploring serine-arginine rich splicing factors: potential predictive markers for dysregulation in oral cancer.
BMC Cancer. 2024;24:1094.
PubMed Abstract available

HAN D, Dong J, Wang Q, Li B, et al
Neoadjuvant radiation target volume definition in esophageal squamous cell cancer: a multicenter recommendations from Chinese experts.
BMC Cancer. 2024;24:1086.
PubMed Abstract available

August 2024

HE T, Shi S, Liu Y, Zhu L, et al
Pathology diagnosis of intraoperative frozen thyroid lesions assisted by deep learning.
BMC Cancer. 2024;24:1069.
PubMed Abstract available

ZHANG J, Gong J, Liu H, Zhou W, et al
Prognostic nutritional index predicts lateral lymph node metastasis and recurrence free survival in papillary thyroid carcinoma.
BMC Cancer. 2024;24:1039.
PubMed Abstract available

QI WX, Li S, Li H, Chen J, et al
The addition of pembrolizumab to neoadjuvant chemoradiotherapy did not increase the risk of developing postoperative anastomotic leakage for ESCC: an analysis from a prospective cohort.
BMC Cancer. 2024;24:1029.
PubMed Abstract available

ZHANG C, Wang SF, Zhang YL, Teng CX, et al
Peripheral hemoglobin to albumin ratio predicts prognosis in patients with nasopharyngeal carcinoma underwent concurrent chemoradiotherapy.
BMC Cancer. 2024;24:1012.
PubMed Abstract available

PARK JO, Feng YH, Su WC, Oh DY, et al
Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial.
BMC Cancer. 2024;24:1006.
PubMed Abstract available

SHEYKHBAHAEI N, Tameemi AHA, Koopaie M
Effect of short-term fasting on the cisplatin activity in human oral squamous cell carcinoma cell line HN5 and chemotherapy side effects.
BMC Cancer. 2024;24:989.
PubMed Abstract available

FANG CH, Cheng YF, Lin SR, Lai WY, et al
Establishment of a protocol for rapidly expanding Epstein-Barr-virus-specific cytotoxic T cells with enhanced cytotoxicity.
BMC Cancer. 2024;24:980.
PubMed Abstract available

ALARCON-SANCHEZ MA, Escoto-Vasquez LS, Heboyan A
Salivary 8-hydroxy-2'-deoxyguanosine levels in patients with oral cancer: a systematic review and meta-analysis.
BMC Cancer. 2024;24:960.
PubMed Abstract available

JIANG L, Zhu J, Chen X, Wang Y, et al
Reduction in chemotherapy relative dose intensity decreases overall survival of neoadjuvant chemoradiotherapy in patients with locally advanced esophageal carcinoma.
BMC Cancer. 2024;24:945.
PubMed Abstract available

GUO LF, Rao MY, Yu YF, Lin Q, et al
The addition of nimotuzumab during concurrent chemoradiotherapy improved survival outcomes in locally advanced nasopharyngeal carcinoma patients with optimal response to induction chemotherapy.
BMC Cancer. 2024;24:950.
PubMed Abstract available

NDEMELA LM, Ottoman OM, Chitemo HD, Minja CA, et al
Epidemiological distribution of high-risk human papillomavirus genotypes and associated factors among patients with esophageal carcinoma at Bugando medical center in Mwanza, Tanzania.
BMC Cancer. 2024;24:932.
PubMed Abstract available

July 2024

LIANG J, Fang F, Gao X, Shi J, et al
LncRNA NEAT1 promotes proliferation, migration, and invasion of laryngeal squamous cell carcinoma cells through miR-411-3p/FZD3-mediated Wnt signaling pathway.
BMC Cancer. 2024;24:904.
PubMed Abstract available

CHO BC, Brana I, Cirauqui B, Aksoy S, et al
Pembrolizumab plus epacadostat in patients with recurrent/metastatic head and neck squamous cell carcinoma (KEYNOTE-669/ECHO-304): a phase 3, randomized, open-label study.
BMC Cancer. 2024;23.
PubMed Abstract available

SADAFI S, Choubsaz P, Kazemeini SMM, Imani MM, et al
Glutathione S-transferase theta 1 (GSTT1) deletion polymorphism and susceptibility to head and neck carcinoma: a systematic review with five analyses.
BMC Cancer. 2024;24:885.
PubMed Abstract available

HIRATA K, Yoshida K, Katada C, Watanabe A, et al
Definitive chemoradiotherapy with paclitaxel for locally advanced esophageal squamous cell carcinoma in older patients (PARADISE-1): a phase I trial.
BMC Cancer. 2024;24:873.
PubMed Abstract available

ZHONG Y, Sun R, Li W, Wang W, et al
Risk factors for esophageal anastomotic stricture after esophagectomy: a meta-analysis.
BMC Cancer. 2024;24:872.
PubMed Abstract available

XIAO L, Liu Y, Zhang X, Nie X, et al
Prognostic value of sarcopenia and inflammatory indices synergy in patients with esophageal squamous cell carcinoma undergoing chemoradiotherapy.
BMC Cancer. 2024;24:860.
PubMed Abstract available

DIETZE A, Neyer PJ, Speth MM, Metzler P, et al
Therapy-Associated Saliva and Taste change Evaluation (TASTE) in head & neck cancer patients undergoing radiotherapy: a study protocol.
BMC Cancer. 2024;24:865.
PubMed Abstract available

KY TD, Loan NT, Thinh NT, Binh MT, et al
Nonadherence to oral cancer chemotherapy in hepatocellular carcinoma: prevalence and predictive factors in Vietnam.
BMC Cancer. 2024;24:841.
PubMed Abstract available

VIRK J, Gill J, Fekrmandi F, Iovoli A, et al
Association of low adherence to weekly cisplatin with outcomes in patients with head and neck squamous cell carcinoma: a retrospective cohort study.
BMC Cancer. 2024;24:838.
PubMed Abstract available

FARHADI M, Fadavi P, Mohebbi S, Taghizadeh-Hesary F, et al
A new approach to prevent radiation-induced xerostomia using intraglandular injection of mitochondria-boosting agents.
BMC Cancer. 2024;24:832.
PubMed Abstract available

NANKIVELL P, Gaunt P, Gaunt C, Sissons J, et al
PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trial.
BMC Cancer. 2024;24:823.
PubMed Abstract available

CHAI J, Su M, Zhang R, Li N, et al
Selective anti-tumor activity of glutathione-responsive abasic site trapping agent in anaplastic thyroid carcinoma.
BMC Cancer. 2024;24:816.
PubMed Abstract available

ZHOU B, Liu J, Yang Y, Ye X, et al
Ultrasound-based nomogram to predict the recurrence in papillary thyroid carcinoma using machine learning.
BMC Cancer. 2024;24:810.
PubMed Abstract available

LI W, Li Y, Gao S, Huang N, et al
Integrating lipid metabolite analysis with MRI-based transformer and radiomics for early and late stage prediction of oral squamous cell carcinoma.
BMC Cancer. 2024;24:795.
PubMed Abstract available

LIN S, Zhou H, Chen G, Xue J, et al
Early change of plasma Epstein-Barr virus DNA load and the viral lytic genome level could positively predict clinical outcome in recurrent or metastatic nasopharyngeal carcinoma receiving anti-programmed cell death 1 monotherapy.
BMC Cancer. 2024;24:797.
PubMed Abstract available

CHENG Y, Song Z, Cheng J, Tang Z, et al
JARID2, a novel regulatory factor, promotes cell proliferation, migration, and invasion in oral squamous cell carcinoma.
BMC Cancer. 2024;24:793.
PubMed Abstract available

June 2024

ALIM N, Elsheikh M, Satti AA, Tabassum N, et al
Recurrence of oral squamous cell carcinoma in surgically treated patients at Khartoum Teaching Dental Hospital retrospective cross-sectional study.
BMC Cancer. 2024;24:781.
PubMed Abstract available

ZHANG M, Li Z, Yin Y
Association of effective dose to immune cells and vertebral marrow dose with hematologic toxicity during neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma.
BMC Cancer. 2024;24:779.
PubMed Abstract available

WONGPATTARAWORAKUL W, Choi A, Buchakjian MR, Lanzel EA, et al
Prognostic Role of Tumor-Infiltrating Lymphocytes in Oral Squamous Cell Carcinoma.
BMC Cancer. 2024;24:766.
PubMed Abstract available

HUA X, Xu F, Shi W, Long ZQ, et al
Prognostic significance of platelet?to?albumin ratio in patients with nasopharyngeal carcinoma receiving concurrent chemoradiotherapy: a retrospective study of 858 cases.
BMC Cancer. 2024;24:762.
PubMed Abstract available

ATULA M, Atula T, Aro K, Irjala H, et al
Psychosocial factors and patient and healthcare delays in large (class T3-T4) oral, oropharyngeal, and laryngeal carcinomas.
BMC Cancer. 2024;24:760.
PubMed Abstract available

HU J, Dai C, Ding Z, Pan Y, et al
IKBIP promotes tumor development via the akt signaling pathway in esophageal squamous cell carcinoma.
BMC Cancer. 2024;24:759.
PubMed Abstract available

HU W, Hu J, Huang Q, Gao J, et al
Long-term outcomes after particle radiation therapy in patients with nasopharyngeal adenoid cystic carcinoma.
BMC Cancer. 2024;24:742.
PubMed Abstract available

ZENG W, Xu W, Long W
The association between XPD rs13181 and rs1799793 polymorphism and oral cancer risk: evidence from a meta-analysis.
BMC Cancer. 2024;24:738.
PubMed Abstract available

WANG X, Liu C, Wu H, Gu Y, et al
Basement membrane-associated gene expression as a predictor of survival in oral cancer.
BMC Cancer. 2024;24:731.
PubMed Abstract available

XU H, Yang Z, Hu W, Zhou X, et al
CSPG4P12 polymorphism served as a susceptibility marker for esophageal cancer in Chinese population.
BMC Cancer. 2024;24:729.
PubMed Abstract available

XU XL, Xu JH, He JQ, Li YH, et al
Novel prognostic nomograms for postoperative patients with oral cavity squamous cell carcinoma in the central region of China.
BMC Cancer. 2024;24:730.
PubMed Abstract available

HUANG G, Wang Y, Qin B, Zeng J, et al
Global, regional and national burdens of Nasopharynx cancer in the adolescents and young adults from 1990 to 2019 and its predictions.
BMC Cancer. 2024;24:720.
PubMed Abstract available

WANG Y, Li X, Gang Q, Huang Y, et al
Pathomics and single-cell analysis of papillary thyroid carcinoma reveal the pro-metastatic influence of cancer-associated fibroblasts.
BMC Cancer. 2024;24:710.
PubMed Abstract available

SUN Y, Liu Y, Li H, Tang Y, et al
The significance and prognostic value of multifocal papillary thyroid carcinoma in children and adolescents.
BMC Cancer. 2024;24:690.
PubMed Abstract available

PIOREK A, Pluzanski A, Knetki-Wroblewska M, Winiarczyk K, et al
Treatment outcomes of patients with primary tracheal tumors - analysis of a large retrospective series.
BMC Cancer. 2024;24:686.
PubMed Abstract available

WANG L, Liu L, Cao Y, Chen X, et al
Simultaneous integrated boost intensity-modulated radiotherapy (SIB-IMRT) combined with nimotuzumab for locally advanced esophageal squamous cell carcinoma (ESCC): A phase II clinical trial.
BMC Cancer. 2024;24:679.
PubMed Abstract available

VERA R, Castro N, Labiano I, Lecumberri A, et al
The TEOGIC study project: a comprehensive characterization of early onset gastrointestinal cancer in the Northern area of Spain.
BMC Cancer. 2024;24:668.
PubMed Abstract available

May 2024

FANG Q, Yuan J, Zhang X, Dai L, et al
Lymph node metastasis in cutaneous squamous cell carcinoma of the head and neck.
BMC Cancer. 2024;24:656.
PubMed Abstract available

YANG X, Zheng X, Hu S, Huang J, et al
Immune checkpoint inhibitors as the second-line treatment for advanced esophageal squamous cell carcinoma: a cost-effectiveness analysis based on network meta-analysis.
BMC Cancer. 2024;24:654.
PubMed Abstract available

ZHENG DD, Li YY, Yuan XY, Lu JL, et al
Immune cell patterns before and after neoadjuvant immune checkpoint blockade combined with chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.
BMC Cancer. 2024;24:649.
PubMed Abstract available

MOU Y, Liang P, Cheng X, He X, et al
Influence of radiotherapy interruption on esophageal cancer with intensity-modulated radiotherapy: a retrospective study.
BMC Cancer. 2024;24:646.
PubMed Abstract available

ZHOU J, Wang L, Qiu T, Gao H, et al
Long-term follow-up of protective effects on salivary and swallowing structures and improvement of late xerostomia and dysphagia by level IIb optimisation in clinical target volume of nasopharyngeal carcinoma.
BMC Cancer. 2024;24:648.
PubMed Abstract available

ERALP B, Sefer E
Reference-free inferring of transcriptomic events in cancer cells on single-cell data.
BMC Cancer. 2024;24:607.
PubMed Abstract available

RONG Y, Hao Y, Wei D, Li Y, et al
Association between preoperative anxiety states and postoperative complications in patients with esophageal cancer and COPD: a retrospective cohort study.
BMC Cancer. 2024;24:606.
PubMed Abstract available

ZONG L, Liu G, He H, Huang D, et al
Causal association of sleep traits with the risk of thyroid cancer: A mendelian randomization study.
BMC Cancer. 2024;24:605.
PubMed Abstract available

WANG J, Lin J, Wang R, Tong T, et al
Immunotherapy combined with apatinib in the treatment of advanced or metastatic gastric/gastroesophageal tumors: a systematic review and meta-analysis.
BMC Cancer. 2024;24:603.
PubMed Abstract available

DU R, Fan S, Yang D, Wang X, et al
Exploration of lymph node recurrence patterns and delineation guidelines of radiation field in middle thoracic oesophageal carcinomas after radical surgery: a real-world study.
BMC Cancer. 2024;24:596.
PubMed Abstract available

LIU H, Li K, Xia J, Zhu J, et al
Prediction of esophageal cancer risk based on genetic variants and environmental risk factors in Chinese population.
BMC Cancer. 2024;24:598.
PubMed Abstract available

PAN Y, Chen Z, Hong W, Huang Z, et al
A nomogram based on nutritional and inflammatory parameters to predict DMFS and identify beneficiaries of adjuvant chemotherapy in IVA-stage nasopharyngeal carcinoma.
BMC Cancer. 2024;24:578.
PubMed Abstract available

WU WB, Cai WL, Zou YH, You R, et al
Outcomes of patients in nasopharyngeal adenoid cystic carcinoma in the IMRT era: a single-center experience.
BMC Cancer. 2024;24:576.
PubMed Abstract available

ZHANG X, Sun K, Gan R, Yan Y, et al
WNT3 promotes chemoresistance to 5-Fluorouracil in oral squamous cell carcinoma via activating the canonical beta-catenin pathway.
BMC Cancer. 2024;24:564.
PubMed Abstract available

HUANG S, Zhang J, He P, Cui X, et al
Radiation-induced upregulation of FGL1 promotes esophageal squamous cell carcinoma metastasis via IMPDH1.
BMC Cancer. 2024;24:557.
PubMed Abstract available

April 2024

VIANA VELOSO GG, Amaral FD, Nogueira-Rodrigues A
Impact of COVID-19 pandemic among patients with lung and head and neck cancer assisted in a public cancer center in Brazil.
BMC Cancer. 2024;24:539.
PubMed Abstract available

LI C, Li M, Wei W, Wang Z, et al
Association of DOK3 and infiltrated tumor-associated macrophages with risk for the prognosis of Porphyromonas gingivalis-infected oral cancer: a 12-year data analysis of 200 patients from a tertiary teaching hospital, Urumqi, China.
BMC Cancer. 2024;24:534.
PubMed Abstract available

DONG Z, Wang GY, Dai DY, Qin GJ, et al
Correction: Prognostic value of pre-treatment [(18)F] FDG PET/CT in recurrent nasopharyngeal carcinoma without distant metastasis.
BMC Cancer. 2024;24:528.
PubMed

JIANG T, Chen C, Zhou Y, Cai S, et al
Deep learning-assisted diagnosis of benign and malignant parotid tumors based on ultrasound: a retrospective study.
BMC Cancer. 2024;24:510.
PubMed Abstract available

SHEN J, Ma Z, Yang J, Qu T, et al
CircPHGDH downregulation decreases papillary thyroid cancer progression through miR-122-5p/PKM2 axis.
BMC Cancer. 2024;24:511.
PubMed Abstract available

JOHANSSON B, Cajander A, Ahmad A, Ohlsson-Nevo E, et al
The effect of internet-administered support (carer eSupport) on preparedness for caregiving in informal caregivers of patients with head and neck cancer compared with support as usual: a study protocol for a randomized controlled trial.
BMC Cancer. 2024;24:494.
PubMed Abstract available

CIRILLO A, Marinelli D, Romeo U, Messineo D, et al
Correction: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis.
BMC Cancer. 2024;24:487.
PubMed

CHEN Y, Huang Y, Chen X, Chen Z, et al
Efficacy of salvage surgery versus re-irradiation for isolated regional lymph node recurrence in patients with nasopharyngeal carcinoma.
BMC Cancer. 2024;24:483.
PubMed Abstract available

MALEKI Z, Hassanzadeh J, Ghaem H
Correlation between socioeconomic indices and epidemiological indices of thyroid cancer from 1990 to 2019 year: a global ecologic study.
BMC Cancer. 2024;24:467.
PubMed Abstract available

DONG Z, Wang GY, Dai DY, Qin GJ, et al
Prognostic value of pre-treatment [(18)F] FDG PET/CT in recurrent nasopharyngeal carcinoma without distant metastasis.
BMC Cancer. 2024;24:466.
PubMed Abstract available

ELTOHAMI Y, Suleiman A
Survival analysis of Sudanese oral squamous cell carcinoma patients with field of cancerization.
BMC Cancer. 2024;24:473.
PubMed Abstract available

MAN Q, Li P, Fan J, Yang S, et al
The prognostic role of pre-treatment neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy.
BMC Cancer. 2024;24:464.
PubMed Abstract available

YANG Y, Yi Y, Wang Z, Li S, et al
A combined nomogram based on radiomics and hematology to predict the pathological complete response of neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma.
BMC Cancer. 2024;24:460.
PubMed Abstract available

IDEL C, Fleckner J, Plotze-Martin K, Werner L, et al
Partial recovery of peripheral blood monocyte subsets in head and neck squamous cell carcinoma patients upon radio(chemo)therapy is associated with decreased plasma CXCL11.
BMC Cancer. 2024;24:459.
PubMed Abstract available

DEUTSCH F, Sais D, Keatinge N, Hill M, et al
Biplex quantitative PCR to detect transcriptionally active human papillomavirus 16 from patient saliva.
BMC Cancer. 2024;24:442.
PubMed Abstract available

ROUTILA E, Mahran R, Salminen S, Irjala H, et al
Identification of stemness-related glycosylation changes in head and neck squamous cell carcinoma.
BMC Cancer. 2024;24:443.
PubMed Abstract available

CAO X, Wang X, Song J, Su Y, et al
Pretreatment multiparametric MRI radiomics-integrated clinical hematological biomarkers can predict early rapid metastasis in patients with nasopharyngeal carcinoma.
BMC Cancer. 2024;24:435.
PubMed Abstract available

CIRILLO A, Marinelli D, Romeo U, Messineo D, et al
Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis.
BMC Cancer. 2024;24:430.
PubMed Abstract available

WANG H, Zhang C, Li Q, Tian T, et al
Development and validation of prediction models for papillary thyroid cancer structural recurrence using machine learning approaches.
BMC Cancer. 2024;24:427.
PubMed Abstract available

CHEN W, Lin G, Chen Y, Cheng F, et al
Prediction of the Ki-67 expression level in head and neck squamous cell carcinoma with machine learning-based multiparametric MRI radiomics: a multicenter study.
BMC Cancer. 2024;24:418.
PubMed Abstract available

AWNY S, Abdallah A, Metwally IH, Abdelwahab K, et al
Impact of age on central lymph nodes involvement in papillary thyroid cancer.
BMC Cancer. 2024;24:423.
PubMed Abstract available

LI J, Gao X, Sun X, Li H, et al
Investigating the causal role of the gut microbiota in esophageal cancer and its subtypes: a two-sample Mendelian randomization study.
BMC Cancer. 2024;24:416.
PubMed Abstract available

AVRY F, Roseau C, Leguay Z, Brabant S, et al
Evaluation of a new score associated with acute kidney injury in patients treated with cisplatin based EXTREME regimen.
BMC Cancer. 2024;24:405.
PubMed Abstract available

KRIELLAARS Y, Vermaire JA, Beugeling M, Poorter R, et al
The effect of physical exercise during radiotherapy on physical performance in patients with head and neck cancer: a trial within cohorts study protocol, the vital study.
BMC Cancer. 2024;24:403.
PubMed Abstract available

March 2024

CUI C, Wang L, Wang X
Effects of physical and psychological symptoms on cancer-related fatigue among esophageal cancer patients.
BMC Cancer. 2024;24:398.
PubMed Abstract available

CHEN Y, Yin M, Zhang Y, Zhou N, et al
Imprinted gene detection effectively improves the diagnostic accuracy for papillary thyroid carcinoma.
BMC Cancer. 2024;24:359.
PubMed Abstract available

DAVAATSEND O, Altannamar M, Ganbat M, Jagdagsuren U, et al
Factors associated with recurrence in patients with oral cancer in Mongolia.
BMC Cancer. 2024;24:356.
PubMed Abstract available

FAN C, Wang X, Zheng X, Sun Y, et al
Consolidation chemotherapy after definitive concurrent chemoradiotherapy in patients with inoperable esophageal squamous cell carcinoma: a multicenter non-inferiority phase III randomized clinical trial.
BMC Cancer. 2024;24:321.
PubMed Abstract available

KHANNA D, Sharma P, Budukh A, Vishwakarma R, et al
Rural-urban disparity in cancer burden and care: findings from an Indian cancer registry.
BMC Cancer. 2024;24:308.
PubMed Abstract available

FUKUDA H, Uehara T, Nakajima T, Iwaya M, et al
A preliminary study of IgG4 expression and its prognostic significance in oral squamous cell carcinoma.
BMC Cancer. 2024;24:294.
PubMed Abstract available

February 2024

HU Z, Wang L, Lu M, Yang W, et al
Protect the recurrent laryngeal nerves in US-guided microwave ablation of thyroid nodules at Zuckerkandl tubercle: a pilot study.
BMC Cancer. 2024;24:271.
PubMed Abstract available

ZHENG T, Wang L, Wang H, Tang L, et al
Prediction model based on MRI morphological features for distinguishing benign and malignant thyroid nodules.
BMC Cancer. 2024;24:256.
PubMed Abstract available

GONG L, Li P, Liu J, Liu Y, et al
A nomogram for predicting adverse pathologic features in low-risk papillary thyroid microcarcinoma.
BMC Cancer. 2024;24:244.
PubMed Abstract available

YANG Y, Tan H, Lu Y, Mei J, et al
Combined score based on plasma fibrinogen and platelet-lymphocyte ratio as a prognostic biomarker in esophageal squamous cell carcinoma.
BMC Cancer. 2024;24:249.
PubMed Abstract available

HUANG X, Chen X, Wan G, Yang D, et al
Mechanism of intestinal microbiota disturbance promoting the occurrence and development of esophageal squamous cell carcinoma--based on microbiomics and metabolomics.
BMC Cancer. 2024;24:245.
PubMed Abstract available

DE MORAES FCA, Pasqualotto E, Chavez MP, Ferreira ROM, et al
Efficacy and safety of Zolbetuximab plus chemotherapy for advanced CLDN18.2-positive gastric or gastro-oesophageal adenocarcinoma: a meta-analysis of randomized clinical trials.
BMC Cancer. 2024;24:240.
PubMed Abstract available

QIU P, Guo Q, Pan K, Lin J, et al
Development of a nomogram for prediction of central lymph node metastasis of papillary thyroid microcarcinoma.
BMC Cancer. 2024;24:235.
PubMed Abstract available

YASSIN-KASSAB A, Chatterjee S, Khan N, Wang N, et al
p90RSK pathway inhibition synergizes with cisplatin in TMEM16A overexpressing head and neck cancer.
BMC Cancer. 2024;24:233.
PubMed Abstract available

YU XW, She PW, Chen FC, Chen YY, et al
Metabolic subtypes and immune landscapes in esophageal squamous cell carcinoma: prognostic implications and potential for personalized therapies.
BMC Cancer. 2024;24:230.
PubMed Abstract available

TAN R, Zhu X, Sun Y, Yang S, et al
The association of HBV infection and head and neck cancer: a systematic review and meta-analysis.
BMC Cancer. 2024;24:225.
PubMed Abstract available

ALMANGUSH A, Hagstrom J, Haglund C, Kowalski LP, et al
The prognostic role of single cell invasion and nuclear diameter in early oral tongue squamous cell carcinoma.
BMC Cancer. 2024;24:213.
PubMed Abstract available

JAKSTAS T, Bartnykaite A, Padervinskis E, Vegiene A, et al
The association of E2F1 and E2F2 single nucleotide polymorphisms with laryngeal squamous cell carcinoma pathomorphological features.
BMC Cancer. 2024;24:214.
PubMed Abstract available

WU Y, Chen W, Miao H, Xu T, et al
SIRT7 promotes the proliferation and migration of anaplastic thyroid cancer cells by regulating the desuccinylation of KIF23.
BMC Cancer. 2024;24:210.
PubMed Abstract available

ZHU Z, Wang W, Zha Y, Wang X, et al
Development and validation of a nomogram for predicting overall survival in patients with sinonasal mucosal melanoma.
BMC Cancer. 2024;24:184.
PubMed Abstract available

LU RD, Wei ZD, Liu YX, Tian D, et al
Increased resected lymph node stations improved survival of esophageal squamous cell carcinoma.
BMC Cancer. 2024;24:177.
PubMed Abstract available

January 2024

WEI B, Yao J, Peng C, Zhao S, et al
Correction: Clinical features and imaging examination assessment of cervical lymph nodes for thyroid carcinoma.
BMC Cancer. 2024;24:145.
PubMed

SAKAMOTO K, Hiraoka SI, Kawamura K, Ruan P, et al
Automated evaluation of masseter muscle volume: deep learning prognostic approach in oral cancer.
BMC Cancer. 2024;24:128.
PubMed Abstract available

ZHANG Y, Du H, Wang N, Wang L, et al
An update of clinical value of circulating tumor DNA in esophageal cancer: a systematic review and meta-analysis.
BMC Cancer. 2024;24:129.
PubMed Abstract available

LV T, Liu H, Mao L, Song Y, et al
Cancer-associated fibroblast-derived extracellular vesicles promote lymph node metastases in oral cavity squamous cell carcinoma by encapsulating ITGB1 and BMI1.
BMC Cancer. 2024;24:113.
PubMed Abstract available

PAN XB, Lu Y, Wei YS, Yao DS, et al
Efficacy of treatment patterns based on concurrent chemoradiotherapy in patients with stage IIB cervical squamous cell carcinoma.
BMC Cancer. 2024;24:106.
PubMed Abstract available

VAN BEERS MA, Speksnijder CM, van Gils CH, Frederix GWJ, et al
Prophylactic pectoralis major flap to compensate for increased risk of pharyngocutaneous fistula in laryngectomy patients with low skeletal muscle mass (PECTORALIS): study protocol for a randomized controlled trial.
BMC Cancer. 2024;24:76.
PubMed Abstract available

GAO Y, Wang W, Yang Y, Xu Z, et al
An integrated model incorporating deep learning, hand-crafted radiomics and clinical and US features to diagnose central lymph node metastasis in patients with papillary thyroid cancer.
BMC Cancer. 2024;24:69.
PubMed Abstract available

GHASEMIAN A, Sargeran K, Khami MR, Shamshiri AR, et al
Effects of educational interventions based on the theory of planned behavior on oral cancer-related knowledge and tobacco smoking in adults: a cluster randomized controlled trial.
BMC Cancer. 2024;24:45.
PubMed Abstract available

LIU Q, Yuan Y, Shang X, Xin L, et al
Cyclin B2 impairs the p53 signaling in nasopharyngeal carcinoma.
BMC Cancer. 2024;24:25.
PubMed Abstract available

WANG C, Hou Y, Wang L, Yang Y, et al
Analysis of correlative risk factors for radiation-induced hypothyroidism in head and neck tumors.
BMC Cancer. 2024;24:5.
PubMed Abstract available

YU K, Liu S, Lin Z, Song J, et al
Effect of trace element mixtures on the outcome of patients with esophageal squamous cell carcinoma: a prospective cohort study in Fujian, China.
BMC Cancer. 2024;24:24.
PubMed Abstract available

December 2023

XU H, Li W, Zhang H, Wang H, et al
Preliminary evidence for endoscopic surgery combined with postoperative anti-PD-1 immunotherapy in advanced recurrent nasopharyngeal carcinoma.
BMC Cancer. 2023;23:1259.
PubMed Abstract available

XING J, Gu Y, Song Y, Liu Q, et al
MYO5A overexpression promotes invasion and correlates with low lymphocyte infiltration in head and neck squamous carcinoma.
BMC Cancer. 2023;23:1267.
PubMed Abstract available

ZHOU J, Wei S, Guo X, Huang Y, et al
Correlation between preoperative peripheral blood NLR, PLR, LMR and prognosis of patients with head and neck squamous cell carcinoma.
BMC Cancer. 2023;23:1247.
PubMed Abstract available

PARK HC, Kim H, Kim JY, Lee HY, et al
PSMD1 as a prognostic marker and potential target in oropharyngeal cancer.
BMC Cancer. 2023;23:1242.
PubMed Abstract available

DING C, Guo Y, Zhou Y, He Y, et al
Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial).
BMC Cancer. 2023;23:1237.
PubMed Abstract available

CHE J, Zhao Y, Gu B, Li S, et al
Untargeted serum metabolomics reveals potential biomarkers and metabolic pathways associated with the progression of gastroesophageal cancer.
BMC Cancer. 2023;23:1238.
PubMed Abstract available

WEI B, Yao J, Peng C, Zhao S, et al
Clinical features and imaging examination assessment of cervical lymph nodes for thyroid carcinoma.
BMC Cancer. 2023;23:1225.
PubMed Abstract available

ZHAO J, Zhang S, Guo X, Li C, et al
PD-1 inhibitors combined with paclitaxel and cisplatin in first-line treatment of esophageal squamous cell carcinoma (ESCC): a network meta-analysis.
BMC Cancer. 2023;23:1221.
PubMed Abstract available

WU S, Yuan X, Huang H, Li Y, et al
Nomogram incorporating Epstein-Barr virus DNA and a novel immune-nutritional marker for survival prediction in nasopharyngeal carcinoma.
BMC Cancer. 2023;23:1217.
PubMed Abstract available

HELENE C, Conrad O, Pflumio C, Borel C, et al
Dynamic profiling of immune microenvironment during anti-PD-1 immunotherapy for head and neck squamous cell carcinoma: the IPRICE study.
BMC Cancer. 2023;23:1209.
PubMed Abstract available

WANG YJ, Xie XF, He YQ, Bao T, et al
Impact of perioperative decreased serum albumin level on anastomotic leakage in esophageal squamous cell carcinoma patients treated with neoadjuvant chemotherapy followed by minimally invasive esophagectomy.
BMC Cancer. 2023;23:1212.
PubMed Abstract available

GAO J, Lan J, Liao H, Yang F, et al
Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges.
BMC Cancer. 2023;23:1205.
PubMed Abstract available

ZHENG J, Zhang H, Li S, Kang Z, et al
Prognostic value of Hematoxylin and eosin staining tumor-infiltrating lymphocytes (H&E-TILs) in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy.
BMC Cancer. 2023;23:1193.
PubMed Abstract available

November 2023

LUO J, Xiao W, Hua F, Cao Y, et al
Efficacy and safety of PD-1 inhibitors in recurrent or metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens: a systematic review and meta-analysis.
BMC Cancer. 2023;23:1172.
PubMed Abstract available

ZHOU Q, He Q, He W, Wang C, et al
Clinical value of folate receptor-positive circulating tumor cells in patients with esophageal squamous cell carcinomas: a retrospective study.
BMC Cancer. 2023;23:1171.
PubMed Abstract available

GIOTAKIS AI, Runge A, Dudas J, Glueckert R, et al
Analysis of cells of epithelial, connective tissue and immune differentiation in HPV-positive-, HPV-negative oropharyngeal carcinoma and normal oropharyngeal tissue by immunofluorescence multiplex image cytometry: a preliminary report.
BMC Cancer. 2023;23:1154.
PubMed Abstract available

CUI L, Chen Z, Zeng F, Jiang X, et al
Impact of sex on treatment-related adverse effects and prognosis in nasopharyngeal carcinoma.
BMC Cancer. 2023;23:1146.
PubMed Abstract available

YANG Z, Zuo Q, Liu R, Wu H, et al
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy with or without nimotuzumab in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study.
BMC Cancer. 2023;23:1140.
PubMed Abstract available

CHEN C, Liu Y, Yao J, Wang K, et al
Deep learning approaches for differentiating thyroid nodules with calcification: a two-center study.
BMC Cancer. 2023;23:1139.
PubMed Abstract available

WANG H, Zhou Z, Lin W, Qian Y, et al
MicroRNA-21 promotes head and neck squamous cell carcinoma (HNSCC) induced transition of bone marrow mesenchymal stem cells to cancer-associated fibroblasts.
BMC Cancer. 2023;23:1135.
PubMed Abstract available

ZHENG H, Yin X, Pan T, Tao X, et al
Effect of different surgical approaches on the survival and safety of Siewert type II esophagogastric junction adenocarcinoma: a systematic review and meta-analysis.
BMC Cancer. 2023;23:1130.
PubMed Abstract available

XU T, Zhu C, Song F, Zhang W, et al
Immunological characteristics of immunogenic cell death genes and malignant progression driving roles of TLR4 in anaplastic thyroid carcinoma.
BMC Cancer. 2023;23:1131.
PubMed Abstract available

HU J, Yan J, Chen Y, Li X, et al
ESCO2 promotes hypopharyngeal carcinoma progression in a STAT1-dependent manner.
BMC Cancer. 2023;23:1114.
PubMed Abstract available

SIJBEN J, Rainey L, Peters Y, Fitzgerald RC, et al
Dutch, UK and US professionals' perceptions of screening for Barrett's esophagus and esophageal adenocarcinoma: a concept mapping study.
BMC Cancer. 2023;23:1111.
PubMed Abstract available

ROUSSOT N, Fumet JD, Limagne E, Thibaudin M, et al
A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer.
BMC Cancer. 2023;23:1080.
PubMed Abstract available

WANG X, Yu Y, Ji Y, Ma Z, et al
Clinical characteristics and therapeutic response of differentiated thyroid carcinoma with obesity and diabetes.
BMC Cancer. 2023;23:1077.
PubMed Abstract available

YOKOTA T, Zenda S, Kodaira T, Kiyota N, et al
Novel approach of prophylactic radiation to reduce toxicities comparing 2-step40 with 56-Gy simultaneous integrated boost intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the head and neck, an intergroup phase III
BMC Cancer. 2023;23:1068.
PubMed Abstract available

XU X, Wang W, Tian B, Zhang X, et al
The predicting role of serum tumor-specific growth factor for prognosis of esophageal squamous cell carcinoma.
BMC Cancer. 2023;23:1067.
PubMed Abstract available

KLASEN C, Wuerdemann N, Rothbart P, Prinz J, et al
Sex-specific aspects in patients with oropharyngeal squamous cell carcinoma: a bicentric cohort study.
BMC Cancer. 2023;23:1054.
PubMed Abstract available

SUGAWARA K, Oka D, Hara H, Yoshii T, et al
Survival outcomes of esophageal cancer patients with recurrence after curative treatments.
BMC Cancer. 2023;23:1051.
PubMed Abstract available

October 2023

ZHANG L, Zhou M, Gao X, Xie Y, et al
Estrogen-related genes for thyroid cancer prognosis, immune infiltration, staging, and drug sensitivity.
BMC Cancer. 2023;23:1048.
PubMed Abstract available

TSUCHIHASHI K, Ito M, Arita S, Kusaba H, et al
Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan.
BMC Cancer. 2023;23:1046.
PubMed Abstract available

NATSUKI S, Tanaka H, Nishiyama M, Deguchi S, et al
Significance of CD103(+) tissue-resident memory T cells for predicting the effectiveness of immune checkpoint inhibitors in esophageal cancer.
BMC Cancer. 2023;23:1011.
PubMed Abstract available

LAU HC, Yuan X, Huang H, Zhang M, et al
Fusobacterium nucleatum facilitates proliferation and autophagy by activating miR-361-3p/NUDT1 axis through oxidative stress in hypopharyngeal squamous cell carcinoma.
BMC Cancer. 2023;23:990.
PubMed Abstract available

SHENG L, Zhuang L, Yang J, Zhang D, et al
Radiation pneumonia predictive model for radiotherapy in esophageal carcinoma patients.
BMC Cancer. 2023;23:988.
PubMed Abstract available

MODESTO A, Tougeron D, Tremolieres P, Ronchin P, et al
Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma-randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocol.
BMC Cancer. 2023;23:966.
PubMed Abstract available

NIU X, Liu P, Wang X, Hu C, et al
Is radical radiotherapy with/without surgery an effective treatment in the lymphoepithelial carcinoma of the salivary gland?.
BMC Cancer. 2023;23:968.
PubMed Abstract available

ZHAO Z, Sun Y, Tang J, Yang Y, et al
LRPPRC regulates malignant behaviors, protects mitochondrial homeostasis, mitochondrial function in osteosarcoma and derived cancer stem-like cells.
BMC Cancer. 2023;23:935.
PubMed Abstract available

September 2023

SAFI S, Ahmadzade M, Karimi S, Akbari ME, et al
A registration trend in eyelid skin cancers and associated risk factors in Iran, 2005-2016.
BMC Cancer. 2023;23:924.
PubMed Abstract available

WANG M, Gao M, Chen Y, Wu J, et al
PLCD3 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/P21 signaling.
BMC Cancer. 2023;23:921.
PubMed Abstract available

MA X, Pierce E, Anand H, Aviles N, et al
Early prediction of response to palliative chemotherapy in patients with stage-IV gastric and esophageal cancer.
BMC Cancer. 2023;23:910.
PubMed Abstract available

HUANG Q, Chen J, Huang Y, Xiong Y, et al
The prognostic role of coagulation markers in the progression and metastasis of laryngeal squamous cell carcinoma.
BMC Cancer. 2023;23:901.
PubMed Abstract available

ZHANG Y, Chen Y, Chen R, Zhou H, et al
YTHDF3as a prognostic predictive biomarker of thyroid cancer and its correlation with immune infiltration.
BMC Cancer. 2023;23:882.
PubMed Abstract available

XU S, Huang H, Dong H, Wang X, et al
Association between surgical extent and recurrence in unilateral intermediate- to high-risk papillary thyroid cancer.
BMC Cancer. 2023;23:880.
PubMed Abstract available

LI C, Guan R, Li W, Wei D, et al
Analysis of myosin genes in HNSCC and identify MYL1 as a specific poor prognostic biomarker, promotes tumor metastasis and correlates with tumor immune infiltration in HNSCC.
BMC Cancer. 2023;23:840.
PubMed Abstract available

DING A, Lv H, Cao J, Wang X, et al
Ultrasonography characteristics of cystic components in primary salivary gland tumors.
BMC Cancer. 2023;23:833.
PubMed Abstract available

SONG D, Ye Z, Chen F, Zhan L, et al
circFNDC3B promotes esophageal squamous cell carcinoma progression by targeting MYO5A via miR-370-3p/miR-136-5p.
BMC Cancer. 2023;23:821.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum